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Abstract

The usage of Computed Tomography (CT) for diagnostic and therapeutic evaluations has
increased dramatically over the past two decades. The rising concerns about radiationinduced carcinogenesis have resulted in great efforts in investigating, monitoring and
reporting radiation dose from CT patient examinations. Currently, common CT dose
descriptors of volume CT Dose Index (CTDIvol) and Dose Length Product (DLP) are not
able to characterise patient-specific dose from CT examinations. The aims of this project
were to investigate the CT dose trends at St. Vincent’s Hospital in the last ten years (20072016) and to evaluate the impacts of patient size and tube current modulation (TCM) to the
patient CT dose estimation.
Our investigation of CT dose at St Vincent’s Hospital was followed the 2011 ARPANSA
recommendation’s protocol (section 2.2.1) in Australian National Diagnostic Reference
Levels (NDRLs). A total of 10, 20, 20 and 20 random patients each year for head, chest,
abdomen and chest-abdomen-pelvis scanning have been selected respectively, including
50% male and 50% female adult patients. Further data analysis and investigation in this
thesis are focused on three aspects: (1) the local CT facility DRLs (FDRLs) are calculated
each year for the CT dose trend analysis and compared to the Australian NDRLs; (2) the
patient size effect on the CT patient dose estimation was investigated using the AAPM’s
approximate method of Size Specific Dose Estimate (SSDE) and an alternative SSDE
calculation method using average CTDIvol has been proposed to account for the TCM
effect; (3) the verification of patient size and TCM impacts on patient skin dose was
evaluated with an anthropomorphic phantom using the CMRP’s MOSkin dosimeters.
Our results show that both CTDIvols and DLPs from the CT facilities at St Vincent’s
Hospital were generally under the Australian National Diagnostic Reference Levels in the
past ten years (2007-2016). The year-to-year variations are correlated with either the CT
scanner or scanning protocol upgrades. The CTDIvols for individual patient examinations
12

exhibit large variations with patient size. The patient-size dependent variations are
significantly reduced by SSDEs instead of CTDIvol. Our proposed SSDE calculation
method shows high agreement with the AAPM approach but also high computing
efficiency. The results from the phantom experiments show that TCM has significant
impact on the skin dose related to patient’s size. The non-TCM scan has higher skin dose
than the TCM scan. The dose reduction impact of TCM scan is significant on small size
patients.
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Chapter 1 Introduction

1.1 Background and Motivation
Computed Tomography (CT) is a leading medical imaging modality in Radiology. The use
of CT for diagnostic and therapy evaluations has increased dramatically over the past two
decades (Australian Radiation Protection and Nuclear Safety Agency, ARPANSA, 2011).
In United States, the number of CT scans increased by 33 million in ten years from 1990 to
2000 (McCollough et. al. 2009). In Australia the use of CT has increased 76.1% from 2007
to 2015 (ARPANSA, 2015B). Since, CT delivers substantially higher radiation doses than
conventional X-ray radiography, the increased utilization of CT has resulted in a significant
rise of radiation doses to the population. The National Council on Radiation Protection and
Measurements indicated that the contribution of CT to medical exposure increased
significantly from 3% in the 1980s to 49% in 2006 (NCRP, 2009).
Along with the increasing referrals for CT examinations, the rising concerns of CT
radiation exposure for secondary cancer risk have had a tremendous impact on the medical
radiation imaging community. The crucial quantity for assessing the risk of cancer from Xray imaging procedures is the radiation dose to individual patients. Management of CT dose
exposure to patient population has become an important issue. This has driven the
evolution of CT technology not only on the improvement of CT image quality but also on
reduction of CT doses to patients. It has resulted in some advanced dose reduction
technologies, such as Tube Current Modulation (TCM), and optimization of CT scanning
15

techniques utilized in the modern CT scanners based on the ALARA (As Low As
Reasonably Achievable) principle. Another major consequence from the concerns
regarding CT dose has been the recommendation of reporting and tracking of radiation dose
for individual patients using patient DICOM dose report.
However, currently patient dose is reported using the CT exposure measures CTDIvol
(volume CT dose index) and DLP (dose-length product). Neither of these quantities is a
patient-specific dose. Accurate estimation of CT dose to individual patients has been a very
challenging topic in CT dosimetry because patient doses from CT examinations are
influenced by many factors, including equipment-related factors, patient related factors and
application specific factors. Physical measurements of individual patient doses during CT
examinations are not feasible in clinical practice. There are two major approaches in
research to improve the quantification of patient-specific CT dose estimations. One is
Monte Carlo (MC) simulation that is considered as a reasonable alternative to the physical
dose measurements. However, the major limitations of MC based method are the high
computation demand and limited patient models. An alternative approach is an
approximation method that makes use of look-up tables, which utilize CT scanner-reported
CTDIvol and a patient size metric to estimate the patient specific dose. The American
Association of Physicists in Medicine (AAPM) Task Group 204 (2011) and Task Group
220 (2015) have published reports to calculate Size Specific Dose Estimates (SSDE).
However, the clinical limitations restricted the possibility AAPM suggested approach.
Regarding the efforts in monitoring and reporting radiation dose from CT examination, the
NCRP (2009) has recommended the establishment of diagnostic reference levels (DRLs) as
a tool for optimizing the radiation dose delivered to patients in the course of diagnostic
16

and/or therapeutic procedures. The Australian national DRLs for multi-detector CT has
been published in 2008 (ARPANSA, 2008A) and a recent update in July 2017 (ARPANSA,
2017). According to the ALARA principle, continuously updated national diagnostic
reference levels (NDRLs) are recommended in order to incorporate the changes in
technology, acquisition protocols and clinical applications, and furthermore, comparison
between facility and national reference levels should be undertaken regularly to maintain
currency (ARPANSA, 2015A).

1.2 Research scope and aims of this thesis
The overall purpose of this project is to better understand CT dose to patients with the
ultimate goal to improve patient dose estimation from CT examinations. The research
project presented in this thesis was initiated by the St. Vincent’s Hospital at Sydney, whose
need was to investigate the CT dose trend to patients in the diagnostic CT examinations
carried out in last ten years (2007-2016) and to compare the facility typical CT doses with
the Australian NDRLs (ARPANSA, 2011). The project was then extended to the
investigation of the impact of tube current modulation on the SSDE estimations. The
specific aims of this study were:


Evaluate how the historical local diagnostics CT dose trends in St. Vincent’s
Hospital compare to the Australia national DRLS and maximize the patients’
benefit from CT examinations following ALARA.



Develop an efficient SSDE method to estimate patient dose by taking into account
the effect of TCM.
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Evaluate experimentally the impact of TCM on patient radiation exposure using an
anthropomorphic phantom.

1.3 Thesis structure
The structure of this thesis is as following


In Chapter 1 the background, the motivation, and the scope of this study are
introduced.



In Chapter 2 the physical parameters which influence the CT dose based on CT
scanner, operator and patient are discussed together with the modern CT scanners
reduction strategies such as Automatic Exposure Control (AEC) and TCM. Other
dose estimations, such as that SSDE are presented describing their advantages and
limitations. In this chapter MOSFET and the MOSkin detectors used in this work
are also introduced.



Chapter 3 presents the methodology of this study. It describes in details the
CTDIvol and DLP quantities and the theory behind a modified SSDE quantity
based on the investigation of TCM.



In Chapter 4 the results of CT dose trend in St. Vincent’s Hospital from 2007 to
2016, the SSDE results of abdominal CT scan patients and the surface CT dose on
an anthropomorphic phantom relating TCM and size impacts are shown.



Chapter 5 discusses the results of this study and suggestions, future directions and
improvements.
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Chapter 2 Literature review

In this chapter we focus on an overview study of the CT dose descriptors and their
limitations for patient dose estimations, the physical parameters influencing the CT dose,
and the proposed MOSFET dosimeter for potential CT dose measurements.

2.1 Physics aspects related to CT dosimetry
The general concepts and principle about patient dosimetry, and the fundamental physics
attributed to CT dose can be found in the excellent textbook of Bushberg et al (2012) and
IAEA Handbook on Physics of Diagnostic Radiology (2014). The investigations in this
section would focus on the physical parameters influencing on the CT dosimetry.
2.1.1 CT acquisition parameters influencing CT dose
During a CT investigation the incident beam of x-rays passes through the scanned object
and after being attenuated, strikes the detectors on the other side of the object. From the
transmitted x-rays trans-axial image can be reconstructed. The energy and photon fluence
of the x-ray beam are the important factors that affect radiation exposure and CT image
quality.
CT tube voltage (kVp)
The x-ray beam energy depends on tube potential (kVp), which can affect both tissue
contrast and image noise (Christian & Waterstram-Rich, 2012; Goldman, 2007). The
decrease of tube potential will increase image noise though can decrease the dose to
19

patients. Kalra et. al. (2004) indicated that the dose change is proportional to the square of
the tube voltage change and the noise change is inversely proportional to the tube voltage
change. With lower tube potential with constant current, the CT dose will be smaller;
however, the CT image quality will be degraded (Kalra et. al., 2004).
CT tube current time product (mAs)
The number of photons emitted by the x-ray tube, i.e. photon fluency, is proportional to the
tube current (Christian & Waterstram-Rich, 2012). Similar to the tube potential, higher tube
current and same scanning time can improve the image quality (low noise) but also increase
CT dose. In the same way, the reduction of CT tube current or tube potential can cause both
the reduction of CT image quality and the reduction of CT dose.
Pitch factor
A patient -clinic-need dependent pitch is defined as the ratio of CT table movement per
rotation divided by the slice thickness (or the full width of half maximum, FWHM,
ARPANSA, 2011). The continuous table movement and the rotation of high speed tube can
both increase the artefacts of CT due to the insufficient reconstruction information of an
image (Nagel, 2000; McCollough, 2009). Theoretically, the increase of pitch can reduce the
scan time and x-ray tube heating (Goldman, 2007). However, increasing pitch can increase
the CT artefacts due to an increase in the number of photons contributing to the image and
therefore have greater risk of missing small lesions (Goldman, 2007). Wang and Vannier
(1999) found that with different pitch number helical/spiral CT scans had similar effect on
images with appropriate interpolation and furthermore, for different angles with pitch 1 the
z-spacing (which is the spacing along z direction) of scanning will not be improved. Then
20

the overlap of detector width is needed (Goldman, 2007). Christian & Waterstram-Rich
(2012) suggested that small pitch can generate more overlapping therefore, CT scanners
can detect small lesions and smooth images at the price of increasing subsequent
reconstruction time. Goldman (2007) gave a rough calculation of the common pitch number
for helical/spiral CT: (N-1)/N, where N is the slice number. From Goldman’s calculation
the favorite pitch number for helical/spiral CT is always less than 1.
Slice thickness and collimation
The slice thickness contributes to the CTDI and DLP values and can be adjusted based on
clinician’s viewing purpose (Nagel, 2000; Christian & Waterstram, 2012). The slice
thickness depends on collimation width (Christian & Waterstram, 2012). There are two
collimators. The first one is primary collimation close to x-ray source to limit the beam to
patient size to reduce patient exposure. The second one is secondary collimation close to
detector to reduce the scattering. In general, the smaller the inter-slice distance or pitch
factor the higher the patient dose (Nagel, 2000).
Beam shaping filters
The x-ray beam shaping usually includes a bowtie filter and/or flat filters. These filters can
modify the energy spectrum and spatial distribution of the x-ray beam. So a change in beam
shaping filters affects the CT dose output from the scanner.
2.1.2 Impacts from automatic dose reduction strategies and manufactural modules
Automatic Exposure Control (AEC)
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Based on Brooks and Chiro’s (1976) fundamental theory, the commonly used technology
for reduction of CT dose is Automatic Exposure Control (AEC, McCollough et al. 2009).
CT systems can automatically adjust the x-ray tube current with the variations in x-ray
intensity at the detector (Nagel, 2000; McCollough et al. 2009). McCollough et al. (2009)
indicated that AEC is the effective method to reduce the CT dose (20-40% reduction) and
that the tube current variates in response to the difference of x-ray intensity at the detector
or the exposure. However, McCollough et al. (2009) suggested that for large size patients,
the increase of tube current may not increase the CT dose due to the fact that some CT
doses are absorbed by fat tissue rather than essential organs.
Tube Current Modulation (TCM)
Modern CT scanners automatically adjust the parameters to achieve a particular level of
detector signal that control s the adjustment of tube current and/or to reduce CT dose (Kalra
et. al., 2004; McCollough, et. al., 2009). Tube current modulation (TCM) is a typical one of
the dose modulation techniques, which varies to compensate for changes of attenuation in
different anatomic regions following Angular Modulation and Longitudinal (z-axis)
Modulation (McCollough et al. 2008, 2009).
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Figure 1 Tube Current Modulation related with the scanning distance along the z-axis (cited from
McMillan, 2015).

The TCM is the variation of tube current within patient absorption with projection angle
and anatomic region (McCollough, 2009). The tube current modulation is based on the
contribution of pixel noise to the projections (Kalra, et al., 2004). The modulation variation
depends on the scanning angle along the scanning axis of the patient or, on the attenuation
differences within the patient in different body regions.The superimposed tube current on
CT projection radiograph showed that the prescribed tube current depends on the
attenuation data from CT projection and manufacturer algorithm. With lower attenuation,
such as in the chest due to the air in the lungs, the tube current was adjusted to a lower
value automatically compared to the other parts of body. The head and pelvis have the
highest current due to higher attenuation (bones) projection data. The tube current
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modulation mode adjusts the current automatically and potentially reduces the total dose to
patients compared to constant current during one single scan (McCollough, 2009).
Supanich (2013) and McNitt-Gray (2010) indicated that the use of AEC may decrease or
increase CTDIvol which is dependent on two factors: patient size and image quality
requested. AEC models assume that the patient is in the isocentre and correct positioning of
the patient has an impact on the delivered dose. With a 20% increase of table height above
the isocenter the CTDIvol can increase by 5% for a Philips Brilliance 64 CT scanner
(Supanich, 2013). Furthermore, the CTDIvol will increase by 60% (Supanich, 2013) when
the tube current increases to maximum value during the AEC process for a Philips
Brilliance 64.

2.2 Issues in current CT dose description and estimation
2.2.1 Current CT dose report and diagnostic reference levels in Australia
The CT dose report is automatically generated after the scan is complete for all modern
commercial scanners.

24

Figure 2 Screenshot of CT dose report created by Philips Brilliance 128 CT scanner.

The report value is highly dependent on the CT scanner’s physical parameters and can
supply important information to evaluate CT dose received by a patient based on two
standard cylindrical phantoms, a 16 cm diameter phantom for the head and a 32 cm
diameter phantom for the body. In the report the most important information is the
exposure (mAs), the potential (kVp), the CTDIvol (mGy) and the DLP (mGy.cm). The
current and the potential are essential to estimate the total radiation doses from CT scanner.
CTDIvol is the CT dose index over the average volume during CT scan (ARPANSA, 2011).
If the scanning direction on the scanning object is in the z direction, then the cross section
will be the area including x and y directions of scanning object with normal single slice
thickness (z). DLP is the dose length product, which is the sum of dose estimation of each
slice along scanning direction on scanning object. From the definition DLP is the CTDIvol
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times the scanning length along z direction. The details of the CTDIvol and DLP
calculations will be introduced.
Current Australian National Diagnostic Reference Level table (NDRL, ARPANSA, 2011)
is a result of 80 radiology facilities registered for the service in 2011 with total 255
compliant individual surveys completed. The 75th percentile of 80 facility reference levels
was chosen to be the Australian National Diagnostic Reference Level for CTDIvol or DLP.
ARPANSA (2011) and IAEA (1999, No. 28) applied different DLP and CTDIvol reference
levels for adults and children and indicated that the DRLs can be varied in different
countries and regions. The ARPANSA (2011) DRLs are current Australian diagnostic
reference levels.
Table 1 Australian Adult (15+ years) Multi Detector Computed Tomography Diagnostic Reference
Levels (cited from ARPANSA, 2011)
DLP (mGy.cm)

CTDIvol (mGy)

Head

1000

60

Neck

600

30

Chest

450

15

Abdomen + Pelvis

700

15

Chest + Abdomen + Pelvis

1200

30

Lumbar Spine

900

40

The diagnostic reference levels in Table 1 are the 75th percentile of median values which
are suitable for the median values of the whole patient population who received a CT scan
in different facilities. The median value of the whole patient population in a facility is
Facility Diagnostic Reference Level. Generally, patient doses should always be maintained
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at lowest levels, which are reasonably practicable and consistent with the clinical purpose
of the examination (IAEA, 1999, No.28). In Australia the survey started in 2011 therefore
there were no DRLs before 2011 and the 2011 DRLs have been used until 2015. Therefore
the NDRLs established in 2011 have been used in current study. ARPANSA (2011)
indicated that the DRL is not a limit but an indicator, which can be used by facility to
optimize the protocols if the facility reference level consistently exceeds the DRL. The
recommended diagnostic reference levels table for CT examinations in IAEA (1999, No. 28)
based on pilot study is shown in APPENDIX A.
2.2.2 Conventional CT dosimetry assessment and its limitations
The question of how to estimate the dose to a patient receiving a CT scan arises. The
following approach is based on measurements inside patient-representative phantoms
(Goldman, 2007). The patient is considered as a cylinder. This cylinder includes a few
points with each point receiving different doses from different sources, which includes the
x-ray beam and the scattered radiation from other points within the cylinder. The amount of
dose is affected by the depth and angle against the x-ray tubes. Therefore, the basic
calculation method is to calculate the dose from each point and their summation.
To simplify the calculation the cylindrical phantom for dosimetry has been used. Goldman
(2007) measured different sized cylindrical acrylic phantoms which represented different
parts of human adult body using ionization chambers. The results showed that the dose at
each point in each slice along the scanning direction (z-direction with beam width of full
width at half maximum of dose profile or the slice thickness) includes that when the slice is
scanned and that when other slices are scanned. Simply, the dose profile of one slice along
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the scanning direction includes two components: one is the radiation from the x-ray beam
directly and another one is from the scatterings of other body tissues. The dose of scattering
depends on scanner geometry, collimator design, slice spacing, slice thickness and the
position of the slice.
Goldman (2007) indicated that the reference phantoms are: 32 cm diameter phantom, which
represents an adult chest, abdomen and pelvis regions; and 16 cm diameter phantom, which
represents an adult head or pediatric patient’s whole body. The standard reference phantom
is the phantom with thickness of 150 mm, and 10-mm diameter holes for the ionization
chambers which has standard length of 100 mm. The holes are at the center and at the 3, 6,
9 and 12 o’clock with a depth of 10 mm to the surface. The standard CT dosimetry
phantoms are shown in Figure 3.

Figure 3 The standard CT dosimetry cylindrical acrylic phantoms with holes for dosimeters (cited
from ARPANSA, 2011).
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Then the radiation doses can be calculated directly from the ionization chambers. The doses
are the same at all positions as they are at the center due to reason explained below. All the
peripheral positions are accounted for set-up uncertainties, phantom positioning, tube
scanning method, etc.
Computed Tomography Dose Index (CTDI)
Currently computed tomography dose estimation indicator is called Computed Tomography
Dose Index (CTDI, unit mGy, IAEA, 1999, No. 28; ARPANSA, 2011, 2015A). The CTDI
was introduced using dose profile for a single slice CT scan (Nagel, 2000; Goldman, 2007).
The measurement approach of CTDI is shown in Figure 4

Figure 4 Computed Tomography Dose Index (CTDI) illustration (cited from Nagel, 2000)

In Figure 4 , the International Atomic Energy Agency Radiation Protection of Patients
(IAEA, 1999, No.28) defined that the CTDI is the integral of point dose along the z-
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direction (or scanning direction) of the dose profile (D(z)) for a single slice and divided by
the nominal slice thickness (or the half maximum full width, T), which is shown below
1

+∞

𝐶𝑇𝐷𝐼 = 𝑇 ∫−∞ 𝐷(𝑧)𝑑𝑧…………………………………………………………...……. (1)
At same time IAEA (1999, No. 28) defined that the CTDI which is calculated with a
commonly used chamber with an active length of 100 mm is 𝐶𝑇𝐷𝐼100(mGy to air). Z is the
scanning length from the start point to the end scanning point. For multi-slice scanning the
T value is replaced by nT, where n is the number of slices. Then the total z-direction beam
width is nT. The formula can be shown below for a multiple slice scan
1

+∞

𝐶𝑇𝐷𝐼 = 𝑛𝑇 ∫−∞ 𝐷(𝑧)𝑑𝑧……………………………………………….…………….…... (2)
Goldman (2007) interpreted CTDI differently for single slice scan as below
𝐶𝑇𝐷𝐼𝐿 (𝑖𝑛 𝑟𝑎𝑑𝑠 𝑜𝑟 𝑐𝑒𝑛𝑡𝑖𝑔𝑟𝑎𝑦𝑠) =
𝐿

(𝑐ℎ𝑎𝑚𝑏𝑒𝑟 𝑟𝑒𝑎𝑑𝑖𝑛𝑔 𝑖𝑛 𝑟𝑜𝑒𝑛𝑡𝑔𝑒𝑛𝑠) × 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛𝑓𝑎𝑐𝑡𝑜𝑟 × 0.87 × .......................… (3)
𝑇
Where L is the active length of the chamber and T is slice thickness for single slice
scanning (nT for multi-slice scan). 0.87 is the f-factor which represents the conversion
factor between exposure and absorbed dose or converts between the ionization in air and
the absorbed dose in tissue. Goldman’s interpretation is under the assumption that the entire
radiation dose received by the chamber was from the scanned slice with thickness T only.
However, this assumption does not consider the length of the dosimeter relative to slice
thickness. Suzuki and Suzuki (1978) used a pencil-shaped-ionization chamber to measure
the exposure resulting from a CT scan. The result showed that the doses of the chamber
detected at different positions were different. The dose at the center of the phantom was
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lower than periphery and the longer chamber can detect more dose than the shorter chamber.
Goldman (2007) explained the results in terms of the scatter (the secondary radiation) can
increase significantly towards the center while the primary radiation is higher at periphery.
Boone (2007) studied the efficiency of CTDI with different collimated beam width. The
results showed that the efficiency of CTDI depends on the hole location in the polymethylmethacrylate (PMMA) CT dosimetry phantom. Therefore, IAEA (1999, No.28) defined the
standard length of the chamber as 100 mm to maintain the chamber long enough to detect
the radiation from both the center and the periphery of the phantom, which can cover both
primary and scatter radiation doses.
Modified CTDI
The modified CTDI is the average CTDI, defined by IAEA as an estimate of the average
dose in a CT dosimetry phantom and simplified as CTDIw or weighted CTDI. CTDIw is
the approximated value of average dose over a single slice CT scan with a unit of mGy. The
presentation of CTDIw showed the availability of the comparison between clinical CTDI
(patients’ dose estimates) and reference CTDI (standard phantom’s dose estimates). IAEA
(1999, No. 28) introduced CTDIw as below
2

1

𝐶𝑇𝐷𝐼𝑊 = (3) × 𝐶𝑇𝐷𝐼100,𝑝𝑒𝑟𝑖𝑝ℎ𝑒𝑟𝑦 + (3) × 𝐶𝑇𝐷𝐼100,𝑐𝑒𝑛𝑡𝑒𝑟 ….......................................... (4)
In equation (4) 𝐶𝑇𝐷𝐼100,𝑝𝑒𝑟𝑖𝑝ℎ𝑒𝑟𝑦 is the 𝐶𝑇𝐷𝐼100 value at the 12 o’clock position and 10
mm below the surface of standard CT dosimetry phantom (see Figure 3). 𝐶𝑇𝐷𝐼100,𝑐𝑒𝑛𝑡𝑒𝑟 is
the 𝐶𝑇𝐷𝐼100 value at the center position. CTDIw is an important value and showed in
IAEA (1999, No 28) reference data table for clinical practice. The normalized weighted
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CTDIw is the average weighted CTDIw is normalized to unit exposure (mAs) shown as
below
𝑛𝐶𝑇𝐷𝐼𝑊

=

1
2

……………………………………... (5)

1

𝐶[( )×𝐶𝑇𝐷𝐼100,𝑝𝑒𝑟𝑖𝑝ℎ𝑒𝑟𝑦 +( )×𝐶𝑇𝐷𝐼100,𝑐𝑒𝑛𝑡𝑒𝑟 ]
3
3

In equation (5), C is the radiographic exposure (mAs). 𝑛𝐶𝑇𝐷𝐼𝑊 has the unit of mGy/mAs.
Equation (5) is used for calculating CTDI in contiguous slices. In contiguous slices the slice
spacing equals the slice thickness (ARPANSA, 2011). For non-contiguous slices and
helical CT scans, the slice spacing is not equal to slice thickness, therefore a packing factor
(p) and helical pitch factor (CT pitch factor) are introduced. If the packing factor is 1 then
the x-ray beams from adjacent rotations are contiguous; if the packing factor is larger than
1, then the x-ray beam overlaps (Goldman, 2007; ARPANSA, 2011). However, the
different case is helical multi-slice CT, which has been introduced in Helical CT. Generally,
the packing factor is defined as the factor that is used to spread the radiation density evenly
over the volume, shown in ARPANSA (2011) as
𝑇𝑁

𝑝 = 𝐼(𝑁−1)+𝑇 =

𝑇𝑁
𝐿

……………………………………………….…………………...…... (6)

Where p is the packing factor, N slices with each slice of thickness, T, and with a couch
increment I and total z-direction length of the examination, L. From the equation the
interpretation is that for contiguous slices the slice spacing equals to slice thickness (TN =
L) then p is one while for non-contiguous slices the slice spacing is not equal to slice
thickness (TN ≠ L then p is not equal to one). In relation to helical CT, the pitch factor is
defined as the ratio of the couch travel in z-direction per rotation of the x-ray tube divided
by the number of tomographic sections produced by a single rotation of the x-ray tube (N)
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and the nominal tomographic slice thickness (T). Simply, the pitch factor for multi-slice
helical CT is the ratio of table movement per rotation to the collimation (ARPANSA, 2011;
Christian & Waterstram-Rich, 2012). Therefore, there is no unit for the pitch factor, which
is shown below
𝐶𝑇 𝑝𝑖𝑡𝑐ℎ 𝑓𝑎𝑐𝑡𝑜𝑟 =

∆𝑑
𝑁×𝑇

………………………………………….…………………… (7)

∆𝑑 is the patient couch travel in horizontal direction, N is the number of tomographic
sections produced by a single rotation of the x-ray tube and T is the nominal tomographic
slice thickness or half maximum full width. Following the CT pitch factor, Goldman (2007)
introduced another indicator, CTDIvol, which is shown as below
𝐶𝑇𝐷𝐼𝑣𝑜𝑙 = 𝐶𝑇𝐷𝐼𝑊 ×

[𝑁×𝑇]
𝐼

=

𝐶𝑇𝐷𝐼𝑊
𝑝

………………………………………………..…….. (8)

𝐼 is the slice spacing for helical CT which is not equal to the slice thickness. CTDIvol is
therefore not dose, rather an estimate of radiation output for a standardized phantom taking
into account scan-specific protocol and pitch. CTDIvol is a dose estimation based on
standardized phantom. McNitt-Grat et al (1999) compared the doses of contiguous axial
and helical scans. The results showed that between contiguous helical and contiguous axial
the doses did not change significantly (101% for contiguous axial and 97% for contiguous
helical both with 1 mm collimation). However, the radiation doses of different helical
pitches were changed significantly (106% for helical pitch 1, but 59.3% for helical pitch 2
both with 1 mm collimation). McNitt-Grat et al (1999) concluded that the phantom should
be placed at gantry isocenter since that the isocenter is exposed uniformly during both
contiguous and noncontiguous scans.
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Dose-length product (DLP)
The introduction of DLP in IAEA (1999, No. 28) is that DLP is another indicator of
exposure for a CT examination for the purpose of comparison and promoting optimization
of patient protection. The DLP was defined as
𝐷𝐿𝑃 = ∑𝑖 𝐶𝑇𝐷𝐼𝑊 ∙ 𝑇 ∙ 𝑁………………………………………………..……………….. (9)
Where, i represents each scan sequence, CTDIw is the weighted CTDI for each of the N
slices of thickness T in the sequence (ARPANSA, 2011). If we combine equations (7), (8)
and (9) and use pitch factor instead of packing factor then another equation (10) will be
obtained as below
0

𝐷𝐿𝑃 = ∑𝑖 𝐶𝑇𝐷𝐼𝑊 ∙ 𝑇 ∙ 𝑁 = ∫𝐿 𝐶𝑇𝐷𝐼𝑣𝑜𝑙 𝑑𝑖 = 𝐿 × 𝐶𝑇𝐷𝐼𝑣𝑜𝑙 …………….……………… (10)
L is the total z-direction scanning length of the examination. DLP represents the energy
transferred to the examined area or specific volume tissue and is proportional to the total
energy transferred to the patient in a completed CT scan along scan length. Therefore, the
unit of DLP is mGy.cm. For example, and abdominal scan would have the same CTDIvol
as an abdominal + pelvis scan however, the abdominal + pelvis scan can have a higher DLP
due to its longer scan length.
In helical scanning, DLP has a similar definition (ARPANSA, 2011), shown as
𝐷𝐿𝑃 = ∑𝑖 𝑛𝐶𝑇𝐷𝐼𝑊 ∙ 𝑇 ∙ 𝐴 ∙ 𝑡………………………………………………………….... (11)
In equation (11), i is each helical slice sequence, T is the slice thickness, A is the tube
current (mA) and t is the total acquisition time (s). All these parameters are from one single
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slice in a series of slices.

𝑛𝐶𝑇𝐷𝐼𝑊

is for a single slice as in a serial scanning. It is easy to

understand equation (11) from equation (5) and (4). For each slice the average weighted
CTDI is under each exposure then when CTDIw is summed up for DLP calculation, all the
exposure should be added up as well (Goldman, 2007).
According to Brooks and Chiro (1976) the dose is related with the energy absorption
coefficient 𝜇𝑒𝑛 , the effective beam width w, the beam height or slice thickness h, and the
correction factor of beam spreading β. The equation is shown as below
𝐷=

𝛽𝑒 𝛼 𝜇𝑒𝑛 𝐸𝑁
100𝑤ℎ

………………………………………………………………………...…. (12)

Where E is the photon energy and N is the number of photons. We know 𝑒 𝛼 = 𝑒 −𝜇𝑑 where
µ is the average attenuation and d is the transverse distance or the object diameter. If the N
is replaced by standard deviation σ or the noise, then the equation will be
𝛽𝑒 𝛼 𝜇

𝐸

𝑒𝑛
𝐷 = 100𝑤ℎ𝜎
2 …………………………………………………………………..………… (13)

Therefore, based on Brooks’ equation, McCollough et al. (2009) indicated that the CT dose
can be affected by beam width, phantom size or patient size. Strauss (2012) indicated that
CTDI or DLP is not patient dose. The evidence shown in Strauss (2012) was that for
example, when identical scan parameters are supplied (kVp, mA, rotation speed and bowtie
filter) for different diameter phantom, measured CTDIvol increases 2.6 times as the
phantom diameter decreases even though the CTDIvol is constant for specified diameter
standard phantom while the dose was supposed to be lower. Strauss (2012) explained the
results as that CTDI phantoms are not real clinical models therefore, CTDI and DLP cannot
represent the patient dose.
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Boone (2007) conducted a study to measure the efficiency of CTDI measurement by Monte
Carlo with collimated beam width from 10 mm to 40 mm and the results showed that the
100 mm ionization chamber can only detect 63% of the energy deposited along the
cylindrical volume in the phantom. Boone (2007) used relatively wide collimated beam
however, the efficiency of CTDI measurement was still low even with 1 mm narrow
collimated beam. The collimated beam width can affect the sharpness of the dose profile
(Goldman, 2007). If the beam width is narrow the dose profile is sharp, which means that
more doses will be dropped in the middle of dose profile rather than the tails of dose profile.
With narrow collimated beam width the efficiency of CTDI measurement was still low,
which showed that the CTDI and DLP cannot represent the patient dose.
However, IAEA (1999, No. 28) and ARPANSA (2015A) are still using CTDI and DLP as
reference indicators of CT irradiation risk for clinical use due to the benefit of the use of
standardized, simple to use and reproducible with historic data comparison phantom. At
same time AAPM (TG204, 2011A) indicated that current CTDI and DLP are based on the
radiation output of standardized phantoms (16 cm diameter for head and 32 cm diameter for
body) and are sensitive to CT scan physics parameters, such as current and voltage.
Therefore, the issues related with CTDI and DLP should be carefully considered. For
smaller size/pediatric patients, the interpreting of CTDIvol/DLP without recognizing the
relationship between size and dose, can cause underestimating patient dose levels by a
factor of 2-3 if the 32 cm phantom was used for reference (AAPM, TG204). The patient
individual size is different and cannot be accurately represented by a standardized reference
phantom with one size. If an adult patient body size is less than 32 cm then the CT scan
parameters should be carefully planned to reduce the dose. When the diagnostic reference
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levels (DRLs) are used for small size patient, the reference values should be lower than the
values obtained from the 32 cm standardized phantom because small size patient should
receive small dose. Then the CT parameters (current, voltage or exposure time) should be
adjusted following facility protocols.
Furthermore, appropriate individual size related diagnostic reference levels are needed, for
example paediatric or small size patients. Therefore, the size specific dose estimates (SSDE)
may be the better indicator than CTDI or DLP. SSDEs calculated under knowing the
phantom diameter and the data (CTDIvol and DLP) represented in dose report. AAPM still
suggested using the standard phantom for the size measurements due to that they are simple
to use, reproducible with historic data comparison. It has been mentioned that the dose
received by patient from a CT scan is dependent on the patient size and scanner radiation
output in ARPANSA (2015A&B) and AAPM (2008, 2009, 2010, 2011 A&B and 2015). In
AAPM (TG204, 2011A) report the authors indicated that CTDIvol can provide only the
scanner output information rather than the patient dose due to the fact-that CTDIvol
calculation does not take the patient size information into account. As mentioned before,
the patient size is an important factor contributing to the CT dose. And AAPM (TG204,
2011A) indicated that the error can be different by a factor of 2-3.
Another issue is that CTDIvol was developed to measure a CT scanner’s output exposure
from a fixed tube current scan. It hasn’t taken into account the effect of tube current
modulation. In fixed tube current CT scans, a single constant tube current value is utilized
along the entire scan length. The reported CTDIvol value may not represent the actual tube
current at a specific table location.
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2.2.3 Effective Dose (ED) and its limitations
CTDI is an average dose estimation of radiation output within a specified volume but not
patient dose (Goldman, 2007; McCollough, 2008). DLP is proportional to the total
deposited energy of patient based on Brooks and Chiro’s (1976) interpretation. Therefore,
the effective dose (ED) was introduced to represent the radio-sensitivity of the irradiated
tissues (ICRP 1977, No. 26; 1991, No. 59 and 2007, No.102&103). The ED can show the
radiation risk for the whole body and a specified volume of partial body. However, the
calculation of ED is complicated. The European Working Group for Guidelines on Quality
Criteria in CT (EU, 1997, 1999 EUR16262) proposed a simple method to calculate ED by
DLP, and which is that DLP multiplies region-specific k factor. The k factor is the value
that depends on the region of the body. The k factor actually represents a more accurate
dose indicator, which can take different size of scanning area into account for CT dose
calculation. Another issue of ED is that the calculation is relative to the organ weighting
factor while CTDIvol or DLP represent the dose estimates of whole body or partial body
rather than separate organs (McCollough & Schueler, 2000). McCollough et al (2009)
indicated that the ED alone cannot represent the radiation risk to specific radiation sensitive
organs or patients of a specific age or gender. Instead of integration of weighting factor
which can affect absorbed dose, McCollough & Schueler (2000) used Monte Carlo method
to calculate the ED and Huda et al (2008) used commercial package to test the ratio of ED
and DLP. The results of these studies showed that the ED is a useful indicator of relative
radiation detriment in diagnostic radiology; however, the limit is that the data were suitable
only for the modelled phantom. These studies tried to find the more accurate indicator to
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show the radiation risk. In these studies CTDI and DLP still play important roles to
evaluate the CT dose irradiation risk.
IAEA (1999, No. 28) gave an alternative estimate of effective dose from values of DLP by
normalized coefficients
𝐸 = 𝐸𝐷𝐿𝑃 ∙ 𝐷𝐿𝑃……………………………………………………………..……….… (14)
DLP is the dose-length product as defined in equation (14) (mGy.cm) and 𝐸𝐷𝐿𝑃 is the
region-specific normalized effective dose (mSv.𝑚𝐺𝑦 −1 𝑐𝑚−1 ). 𝐸𝐷𝐿𝑃 values are shown as
below according to anatomical regions of patient
Table 2 Normalized values of effective dose per dose-length product (cited from IAEA, 1999, No.
28).
Normalized effective dose, 𝑬𝑫𝑳𝑷 (𝐦𝐒𝐯. 𝒎𝑮𝒚−𝟏 𝒄𝒎−𝟏 )
Head

0.0023

Neck

0.0054

Chest

0.017

Abdomen

0.015

Pelvis

0.019

The effective dose is still based on the CT output data (DLP) therefore all the limitations of
CT DRLs can be represented as well.
2.2.4 Size Specific Dose Estimates (SSDE) and its limitations
SSDE is based on the consideration of the accuracy of CT dose estimates of pediatric
patients and small size adults (AAPM, 2011 A&B and 2015). AAPM (2011 A and 2015)
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suggested a different dose estimation approach by combining CT output (CTDIvol) with
individual patient’s specific size information for images interested, which was named as
‘size specific dose estimates (SSDE)’. The SSDE calculation is a product of CTDIvol and
conversion coefficient factor (AAPM TG204, 2011A), which will be introduced in this
chapter. The CTDIvol can be found in CT output DICOM information and the conversion
coefficient is individual size related correction factor. Therefore, SSDE approach actually is
size corrected dose estimation based on current ARPANSA (2011) dose estimate approach
(CTDIvol of DRL). At the same time AAPM (2011A and 2015) applied a conversion
coefficient table used for SSDE calculation based on 16 cm diameter phantom and 32 cm
diameter phantom respectively. Furthermore, AAPM (2011A) mentioned that SSDE
conversion coefficient factor is not used for DLP or effective dose. The conversion factor is
a patient-size-dependent factor which is determined by patient’s three dimensional
diameters.
An important diameter in SSDE calculation is the effective diameter, which is shown in
Figure 5.Two other dimensional diameters are Lateral Dimension (LAT) diameter and AP
Dimension (Anterior-Posterior Dimension) diameter. LAT diameter is the left to right
dimension of the active body part in one slice. AP diameter is the thickness of the body part
being scanned. LAT and AP are easily measured by using CT digital caliper or any
validated software package. The sum of the LAT and AP is proportional to the effective
diameter (AAPM, TG204, 2011A).
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Figure 5 Parameters used for SSDE calculation (cited from AAPM, TG204, 2011)

The effective diameter then is calculated by
𝜋∙

𝑒𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 = 2√

𝐿𝐴𝑇 𝐴𝑃
∙
2 2

𝜋

= √𝐿𝐴𝑇 ∙ 𝐴𝑃………………………………........ (15)

In this formula the patient body in one slice was assumed to be elliptical in cross section
and with two radii, r1= LAT/2, r2= AP/2 respectively. The area of the cross section will be
𝜋∙
𝐴
A=𝜋𝑟1 𝑟2 , and the effective diameter is 2√𝜋 = 2√

𝐿𝐴𝑇 𝐴𝑃
∙
2 2

𝜋

= √𝐿𝐴𝑇 ∙ 𝐴𝑃. AAPM (2011A)

suggested conversion coefficient tables. In the conversion coefficient table the conversion
coefficient factor decreases with the increase of effective diameter. The choice of
conversion coefficient factor regarding different dimensions’ diameters depends on the
interest of the clinical radiologist and the imaging circumstances. In this article two SSDE
calculation approaches will be introduced: alternative average SSDE method in AAPM
(TG220, 2015) and average CTDIvol method, which is proposed in this research study and
not in AAPM.
41

In Task Group 204 (AAPM, 2011A) the geometric size metrics were suggested for patient’s
x-ray attenuation. However, the attenuation results can be different for different regions
with same size, for example, thorax and abdomen. The thorax region has less attenuation
due to that less photons have been attenuated than abdomen region. Therefore, Task Group
220 (AAPM, 2015) has recommended another approach to calculate SSDE by using water
equivalent diameter (Dw) instead of effective diameter. The purpose of the change from
geometric size metrics to attenuation metrics is to develop a robust and scientifically sound
metric for estimating patient size in CT that would account for patient attenuation and allow
routine determination of SSDE for different size patients (AAPM, TG220, 2015). After the
comparison of doses results by using effective diameter approach (Task Group 204) and
water equivalent diameter approach (Task Group 220) based on Monte Carlo study, a better
correlation was observed for Dw than for effective diameter (Khatonabadi, et. al. 2013).
The Dw, water equivalent diameter, is determined by the scanned area of water cylinder
(water equivalent area, Aw), which is calculated by CT numbers in equation 16.
1

̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅
𝐷𝑤 = 2√[1000 𝐶𝑇(𝑥,
𝑦)𝑅𝑂𝐼 + 1]

𝐴𝑅𝑂𝐼
𝜋

………………………………………………….… (16)

̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅
In equation (16) 𝐶𝑇(𝑥,
𝑦)𝑅𝑂𝐼 is the mean CT number in an ROI containing that object. The
𝐴𝑅𝑂𝐼 is the area of the ROI.
After the determination of Dw, the conversion factor table from Task Group 204 can be
used to obtain the conversion factor. Another change in Task Group 220 (AAPM, 2015) is
the determination of CTDIvol. When tube current modulation is applied, scanned output
varies along the longitudinal axis of a patient according to changes in patient attenuation.
The mean scanner output per rotation normalized to the tube-current time product
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(CTDIvol/mAs) can be determined from CT header tags. The current-time product (mAs)
of each image can be found from header information and multiplies the mean effective mAs
per rotation at every image with the nominal CTDIvol/mAs, the scanner output at each
location can be calculated.
Conversion factor
AAPM (2011A&B) summarized four research studies’ results and applied the conversion
coefficient table according to different dimensional diameters, anterior-posterior (AP),
lateral (LAT), sum (AP+LAT) dimensions and effective diameter. Four studies include
McCollough and colleagues’ (2007, 2008) PMMA cylindrical phantom study, Toth and
Strauss’s (Huda, et.al. 2000) physical Anthropomorphic phantoms study, Mcnitt-Gray and
colleagues’ (Turner, et. al. 2011) Monte Carlo Voxelized phantoms study and Boone
(Boone, et. al. 2000) and Zhou’s (Zhou & Boone, 2008) Monte Carlo Mathematical
Cylinders study.
The SSDE results by using conversion coefficient table are slightly higher than the patient’s
average dose and skin dose during entire CT scan volume because the conversion factor
table is based on the dose estimation of center of the scanning length (AAPM, TG204,
2011A). From dose profile the dose at the center of the scanning length is the peak dose and
the doses at the tails of dose profile are smaller. Therefore, the peak dose at the scanning
center is higher than the average dose of the entire scan. The limitations of the conversion
table are pointed out by AAPM (TG204, 2011A). The first limitation of conversion factor
table method is that the conversion factors were obtained from the combined results of four
research groups based on the phantom studies (AAPM, TG204, 2011A). However, in
reality, the patient size is variable. The second limitation of conversion factor table
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approach is which conversion factor table is more reliable. For example, the distance
between the gantry and the patient can affect the LAT dimension diameter. If the distance is
smaller the LAT will be bigger because the patient is shown larger in the scan plane.
Therefore, in AAPM (TG204, 2011A) an experimental approach has been mentioned to
obtain conversion factor for 16 cm phantom and 32 cm phantom respectively
16 cm 𝑦 = 1.8748 × 𝑒 −0.0387𝑥 …………………………………………………………. (17)
32 cm 𝑦 = 3.7044 × 𝑒 −0.0367𝑥 ……………………………………………..………….. (18)
In equations (17) and (18) 𝑦 is the conversion factor; 𝑥 is the effective diameter of the slice.
In this research study equation (17) and (18) will be used to obtain conversion coefficient.
SSDE approaches (AAPM, 2011 and 2015) and limitations
SSDE method specified the patient size for the estimation of patient dose while CTDI
method of current DRL was to integrate all the points’ doses along the scanning length in a
standardized phantom. The CT dose depends on the CT scanner outputs and patient size.
In AAPM (TG204, 2011A) the interpretation of the relationship between SSDE and
CTDIvol shown as
𝐷𝑋
𝑠𝑖𝑧𝑒 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑑𝑜𝑠𝑒 𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒(𝑆𝑆𝐷𝐸) = 𝑓𝑠𝑖𝑧𝑒
× 𝐶𝑇𝐷𝐼𝑣𝑜𝑙 ……………………………... (19)

In equation (19) D is the specified phantom diameter used in CTDI reference data, such as
16 centimeter is for head and pediatric patient; 32 centimeter is for adult body scanning. X
is the specific measurement of size used in SSDE, such as that S is the sum of AP and LAT,
L is the LAT, A is the AP and D is the effective diameter, while
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is the measured

𝐷𝑋
value of specified X. 𝑓𝑠𝑖𝑧𝑒
is the conversion coefficient between specified size and dose

estimates. The equation (19) is only for one image of a series of images in one scan.
Then AAPM (TG 220, 2015) applied the SSDE calculation approach (average SSDE
method) of entire scan of a series of slices by using Dw and CTDIvol as

𝑆𝑆𝐷𝐸 =

∑𝑁
𝑍=1 𝑆𝑆𝐷𝐸(𝑍)
𝑁

…………………………………………………………..………. (20)

In equation (20) 𝑆𝑆𝐷𝐸 is the average SSDE value of a series of slices in an entire scan,
∑𝑁
𝑍=1 𝑆𝑆𝐷𝐸(𝑍)
𝑁

is the sum of all the SSDEs of all slices (z) on a slice-by-slice base and N is the

number of slices of the series of slices. Each SSDE of one single image is calculated by the
mean CTDIvol and the conversion coefficient obtained by Dw of each image.
In average SSDE approach each Dw of each image in an entire scan has to be calculated by
water equivalent area and calibrated to obtain the conversion coefficient and all the SSDEs
have to be averaged following equation (20). This approach is time consuming due to a
large number of slices in an entire scan (for example, 200 slices) and the errors increases
with the increase of the number of slices. Furthermore, the determination of Dw has
practical limitations which reduced the possibility of average SSDE calculation approach.
The water equivalent diameter values would be calculated from projection or full FOV CT
image data. Therefore, the practical limitations, such as the need to perform additional full
FOV images, will increase reconstruction time and create more images to review, transfer,
and archive. Another method to obtain Dw by using CT localizer radiograph needs more
considerations to increase the accuracy of Dw, such as pixel values calibration, the
attenuation of the table, non-edge-enhancing filters use and patient centering issues.
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2.3 MOSFET dosimetry in radiological X-rays
Structure of MOSFET
The metal-oxide semiconductor field effect transistor (MOSFET) has been recognized as a
space-charge dosimeter with ionization effect in the dielectric that causes a potential change
across the dielectric surface which can be measured (Rosenfeld, 2007). MOSFET has pchannel enhancement MOSFET, which is built on a negatively doped (n-type) silicon
substrate and n-channel enhancement MOSFET (on a positively doped silicon substrate).
The MOSFET is a sandwich type device made up of a metal (gate) layer, and insulating
oxide (SiO2) layer and a silicon semiconductor substrate, whose ability to function as a
transistor device depends on the applied voltage Vg that can create a field effect.

Figure 6 P-channel enhancement MOSFET structure (cited from Lian, 2012).

Physics of MOSFET radiation dosimeter
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Figure 7 Physical model of ionizing radiation induced effects in MOS structures, with a positive
gate bias applied. Upon irradiation, 3 major processes dominate in the MOSFET; namely, (1) the
accumulation of trapped charge in the SiO2, (2) the transport of holes through the oxide and (3) the
increase in the number of bulk oxide and interface traps. Cited from Desendorfer and Ma, 1989.

When a negative gate voltage is applied there is a shift threshold voltage, which is the
difference before and after the MOSFET is irradiated and corresponds to the absorbed dose
in the SiO2. The ionizing radiation effects will be shown. Incident ionizing radiation
creates electron-hole pairs within SiO2 layer. The electrons move toward the positive Si
regions. Electron-hole pairs tend to recombine depending on the applied field, energy and
type of incident radiation (Soubra, et. al., 1994). The holes that escape recombination
remain behind near their point of generation. They are relatively immobile and result in
negative voltage shifts of the MOSFET. Within a second at room temperature in response
to the applied electric field, the holes undergo stochastic hopping through the oxide, which
gives rise to a transient recovery in the voltage shift. When the holes are close to the SiSiO2 interface, some of them are captured in long term trapping sites which causes the
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negative voltage shift. This threshold voltage shift is proportional to the total quantity of
trapped charges in the MOSFET, which has a linear relationship with the absorbed dose in
the SiO2.
The angular effect, sensitivity and the thermal effect concerns
The angular dependence has been tested in Roshau & Hintenlang’s (2003) study. The
results showed that for a commercial MOSFET dosimeter, an isotropic response during the
rotations of 360° in15° increments. Furthermore, the deviation to the mean response was
less than 3%. Dong et al. (2003) examined the sensitivity and linearity of MOSFET for
breast entrance skin air kerma. The results showed that MOSFET had high sensitivity and
linearity at the tube potentials between 25-30 kV. While in Benevides and Hintenlang’s
(2005) study showed that all the models of MOSFET dosimeters showed a high sensitivity
and low angular responses between 120-150 degrees and 190-220 degrees. MOSFET has a
finite lifespan due to the saturation of the charge build-up effect in the gate oxide and the
tolerance criterion of non-linearity of dose response therefore the frequent recalibration is
needed (Rosenfeld, 2007). When dose measurements are repeatedly taken and depends on
the time interval, the MOSFET’s threshold voltage increases, which is creep-up effect
(Ramani, et. al. 1997).
For radiotherapy treatment Gurp (2009) and Gambarini et. al. (2012) studied the response
of linear-MOSFET-array for real time dosimetry during prostate brachytherapy. The results
showed that MOSFET dosimetry is suitable to be used in vivo clinical routine verification.
However, they suggested that MOSFET dosimeters overestimated dose values in the
penumbra region and the clinical situations have to be simulated in Linac QA procedure. In
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contrast, Rosenfeld (2007) suggested that MOSFET dosimeters had excellent spatial
resolution, temperature stability and minimal slow border trapping effects for 120 kVp and
6 MV x-ray respectively during Hadron radiotherapy.
However, Koivisto et al. (2015) studied the accuracy of MOSFET dosimeters at low dose
diagnostic x-ray exposure and the results showed that MOSFET had low accuracy in their
study due to type A (statistical) uncertainty. At same time Koivisto et al. (2015) suggested
that this problem can be solved by increasing the number of exposures and averaging the
results. In our thesis experiment the dose measurement will be taken five times and the
average value will be the final result.
Furthermore, Lian (2012) concluded that MOSFET response depends on the readout time
interval. MOSFET response rose rapidly by about 14% during the first 26 hours after
exposure (Lian, 2012).
MOSkin dosimeter
MOSkin is a MOSFET detector developed by the Centre for Medical Radiation Physics
(CMRP) of the University of Wollongong, Australia (Rivard et al. 2004; Qi, 2007; Kwan,
et al. 2008; Kwan, 2009; Kwan, et al. 2009; Hardcastle, 2010); it is a radiation dosimeter of
base dimensions of 2.5 mm x 0.8 mm and thickness of 0.40 mm (Lian, 2012). MOSkin
sensitive SiO2 dose scoring volume is 1µm thick, which is sealed in with the kapton
polyamide layer and sandwiched between the 0.374 mm thick silicon substrate. The silicon
die is surrounded by tissue-equivalent epoxy/alumina. The primary difference between a
conventional MOSFET and the MOSkin dosimeter is the encapsulation used. The
conventional MOSFET uses a hemispherical epoxy bubble which is not reproducible, while
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the MOSkin encapsulation is essentially a highly reproducible, thin film of polyamide that
protects the sensitive volume of the MOSkin. The thickness of the polyamide film depends
on the clinical application of interest. For the measurement of skin dose, the polyamide film
thickness is set to be 70 µm according to ICRP recommendations (ICRP, 1991). MOSkin
showed high sensitivity, reproducibility, energy dependence, broad temperature range and
linearity in vivo clinical performance (Rivard et al. 2004Qi, 2007; Kwan, et al. 2008; Kwan,
2009; Kwan, et al. 2009; Hardcastle, 2010). Furthermore, MOSkin dosimeter is suitable for
surface dose measurement due to small and thin size, which is perfectly useful in this thesis
experiment.

2.4 Summary
As mentioned in IAEA (1999, NO. 28), the current guidelines for CT diagnostic reference
levels, which include the CTDIvol and the DLP, are not suitable to effectively indicate
patient dose estimates. Moreover, the guidelines suggested to use the CT quality criteria,
such as the weighted computed tomography dose index (CTDIw).
The size specific dose estimates (SSDE) approach which is average SSDE across the
scanning length, can measure the dose estimates on patient entrance surface (skin) (Wall,
2001; Dixon, 2003; Huda, et. al. 2004; Brenner, et. al. 2006; AAPM, 2011A&B ; Christner,
et. al. 2012; Leng, et. al. 2015). However, the SSDE approach or the current DRLs from
ARPANSA cannot show any dose estimates of organs. The average SSDE approach
suggested by AAPM (TG204, 2011A) is time consuming due to the large amount of
measurements of all the slices in an entire CT scan and at same time the measurement error
has high possibility to occur. However, the proposed SSDE approach (the average CTDIvol
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approach) has limitations which will be solved in the future study as well: one is the less
accuracy of attenuation information and another one is the validation.
Both the current DRLs and the SSDE approaches are based on the standardized phantom
(ARPANSA, 2015A). The SSDE approaches (both the AAPM approach and the proposal
approach) are based on the 16 cm diameter and 32 cm diameter phantoms to obtain the
conversion coefficient. The standardized phantom is not the representation of a real
patient’s body. Based on these limitations some studies have been conducted by several
researchers (Nickoloff, et. al. 2003; Strauss, 2012; Sahbaee, et. al. 2013; Maryam, 2013;
Leng, et. al. 2015). These studies were based on computerized multi-sized phantom to
represent organs or in a laboratory using different size water-equivalent phantom to
improve the accuracy of organ dose measurements due to that the water-equivalent
phantom is more representative of human tissues and the surrounding surface
measurements in CT are not easily clarified. However, these studies still cannot combine
the organ size and organ density with dose estimation in a clinical reality situation. Simply,
these results are still size-scaled dose estimation rather than energy-related dose estimation.
The benefits of the improving these methods will be significant and shown in not just
overcoming the limitations but consequently improving patient quality of care, safety,
updating national and international guidelines and improving accuracy of future research
based on these new methods.
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Chapter 3 Methodology

3.1 Method for CT dose trends investigation
3.1.1 Patient data sorting protocols
Patient CT images performed within a 10 years period (2007-2016) were selected from the
St. Vincent’s Hospital PACS system (picture archiving and communication system) which
is a medical imaging technology used for economical storage and convenient access to
images from multiple modalities, following the standard method suggested by current
Australian Radiation Protection and Nuclear Safety Agency (ARPANSA, 2011). Patient
selection and CT investigation types are summarized in Table 3.
Table 3 Patients’ selection protocols per year following the ARPANSA standard protocol
(ARPANSA, 2011).
head

chest

abdomen

chestabdomenpelvis

No. of

10

20

20

patients/year
Gender

50% male and 50% female

Age

20-98 years old
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20

For each of one year period in the 10 years interval chosen, 10, 20, 20 and 20 patients (50%
male and 50% female) were randomly selected for head, chest, abdomen and chest +
abdomen + pelvis scanning respectively. The patient age ranged between 20 and 98 years
old.
3.1.2 CTDIvol and DLP trends from 2007-2016 at St. Vincent’s Hospital
CTDIvol trends in last ten years (2007-2016)
For each individual slice in a single scan of one patient, the CTDIvol of the image is
recorded in the image DICOM tags (see Figure 6). The Figure 6 shown below is an
example of DICOM header tags.

Figure 6 The screenshot of information of DICOM header tags of one slice (Philips).

In Figure 6 the numbers are DICOM header tags followed by the particular functions and
the values. The tag 0018, 9311 is the pitch factor with a value of 0.921 and the tag 0018,
9345 is the CTDIvol with a value of 5.98 mGy. Both of the values are from one slice. Then
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the CTDIvol of the entire scan of the patient can then be calculated as the mean CTDIvol
across all the slices on a slice-by-slice base (ARPANSA, 2011).
The Facility Diagnostic Reference Level (FDRL) CTDIvol is calculated as the median
value of the CTDIvols of all the patients in each year. The FDRL CTDIvol is then
compared with the National Diagnostic Reference Level (NDRL) CTDIvol.
DLP trends in last ten years (2007-2016)
From equations (8), (9), (10) and (11), the DLP is the sum of all the slices’ DLPs. Then the
equation for a single scan will be the sum of DLPs of all the slices during the entire CT
scan shown below
𝐷𝐿𝑃 = ∑𝑛𝑖=1 𝑝𝑖𝑡𝑐ℎ 𝑓𝑎𝑐𝑡𝑜𝑟 × 𝐶𝑇𝐷𝐼𝑣𝑜𝑙 × 𝑆𝑙𝑖𝑐𝑒 𝑇ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠…………………………….. (21)
In equation (21) the pitch factor, CTDIvol and the slice thickness are shown in DICOM
header tags automatically for each slice on a slice-by-slice base (Figure 6). The slice
thickness is axial resolution of the scan, which is different with the slice increment. The
slice increment is the movement of table/scanner for scanning next slice. Then the DLP of
one patient is the sum of all the DLPs of all the slices in the entire CT scan. After the DLP
of each patient was obtained for the particular region in the particular year the FDRL DLP
is the median value of all the DLPs of all the patients for that particular region in that
particular year. Then the FDRL DLP will be compared with Australian NDRL DLP.
After the DLP results are obtained for each year the percentages of patients of ten years
(100 patients for head scan, 200 patients for chest, abdomen and chest + abdomen + pelvis
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respectively from 2007 to 2016) who had the DLP values over and below the NDRL will
be examined.

3.2 SSDE calculations
3.2.1 Alternative AAPM (based on TG220, 2015) approach (average SSDE)
Following the AAPM suggestion for the estimation of SSDE values from TCM CT scan,
the SSDE was calculated as the average of the SSDE value for each slice of the scan. Due
to the limitations of determination of Dw we still use effective diameter instead of Dw of
each image and the CTDIvol information was obtained from header tags for each image.
Then following equation (20) the SSDE for each patient will be obtained by average all the
SSDEs from all the images in one entire CT scan of that patient. This approach has been
applied to the patients (70 patients) who received a CT scan in 2016 for any of the four
regions considered in this study (brain, chest, abdomen and chest + abdomen + pelvis). The
SSDE was estimated from the effective patient diameter (equation (15)), where the lateral
(LAT) and the anterior-posterior (AP) diameters were measured manually for each slice of
a series using ImageJ (1.50i/Java 1.6.0_20, and open source software). The conversion
coefficients are given by equation (17) for head scanning images and equation (18) for
chest, abdomen and chest + abdomen + pelvis scanning images respectively.
3.2.2 Proposed approach (average CTDIvol)
SSDE quantity considers the patient size by adjusting the CTDIvol of the central slice by a
specific size factor in order to convert the CTDI air kerma into a size specified estimated
dose (AAPM, 2011A). The idea of Task Group 220 (AAPM, 2015) makes it available that
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the SSDE can be calculated only by the center slice effective diameter and the mean
CTDIvol of entire CT scan.
The dose of CT scanning on object is the energy delivered based on CT physical
parameters (kVp, current, rotation time, bowtie filter and pitch factor) (AAPM, 2011A and
2015). The tube current modulation has commonly been used to reduce the CT dose.
(McCollough, et. al., 2009). Therefore, Dixon (2013) tried to find the relationship between
modulated current and CTDIvol, furthermore, SSDE. Following the dose rate profile
travelling along the central axis (z-axis) Dixon (2013) suggested the dose estimation at any
point (z) along z-axis shown as below
1

𝑖(𝑍)

𝑏

𝑖0

𝐷𝐿 (𝑍) = 𝑓𝑖0 (𝑍) ⊗

𝑍

∏( )………………….....…………………………………….. (22)
𝐿

In the equation 𝐷𝐿 (𝑍) is the dose at any point z along z-axis. b is the table advance per
rotation, which equals to the table speed times the gantry rotation period for helical
CT. 𝑓𝑖0 (𝑍) is the wave function of dose profile in one single rotation with the phantom at
stationary with constant current.

𝑖(𝑍)
𝑖0

is the current correction for tube current modulation,
𝑍

i(z) is modulated current and i0 is constant current. ∏(𝐿 ) is rectangular function which to
limit the point z inside the scanning length L otherwise if point z is outside of scanning
length L the point dose will be counted as zero. Equation (21) is actually the current
modulation corrected dose (with constant current) estimation. If the modulated current is
specified as
1

𝑡0

1

𝐿

< 𝑖 > = 𝑡 ∫0 𝑖(𝑡)𝑑𝑡 = 𝐿 ∫2 𝑙 𝑖(𝑧 ′ )𝑑𝑧 ′ …………………………………….…...……… (23)
0

−

2
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In the equation <i> is the average current during one entire scan with total scanning time t0
and equal to the sum of tube current at any time t divided by total scan time, t0. If the table
velocity v and pitch are constant then 𝑧 ′ = vt and L = v𝑡0 , where L is the total scanning
length and 𝑧 ′ is any dose point. Furthermore, after the combination of equation (21) and
equation (23) Dixon (2013) summarized that
𝑖

𝑇𝐶𝑀
100
(𝑧) = 𝑧 𝐶𝑇𝐷𝐼𝑣𝑜𝑙
|< 𝑖 >…………………………………………..………. (24)
𝐶𝑇𝐷𝐼𝑣𝑜𝑙
<𝑖>
𝐿

In this equation the CTDIvol in tube current modulation (TCM) model has been formulated
as the ratio of the tube current at any point z along scanning path and the average current of
the entire scan multiplies the CTDIvol, which is the value at average current following
standard protocol. This equation (24) is another explanation of the linear relationship
between the energy at any point along scanning path and the energy at average current
point. The CTDIvol and the dose profile measurement are based on the center slice of the
entire scan (Goldman, 2007; AAPM, 2011A, 2015). Therefore, if the average CTDIvol is
the CTDIvol at average current and following the SSDE definition, the SSDE can be
obtained by the average CTDIvol and the conversion factor of the center slice.
Therefore, for a modulated CT scan the SSDE calculation can be updated finally as
𝐷𝑋
𝐷𝑋
𝑇𝐶𝑀
𝐷𝑋
(𝑧) = 𝑓𝑠𝑖𝑧𝑒
𝑆𝑆𝐷𝐸 = 𝑓𝑠𝑖𝑧𝑒
× 𝐶𝑇𝐷𝐼𝑣𝑜𝑙 = 𝑓𝑠𝑖𝑧𝑒
× 𝐶𝑇𝐷𝐼𝑣𝑜𝑙
×
𝑖𝑧
<𝑖>𝐿

100
|〈𝑖〉………………………………………………………………………… (25)
𝐶𝑇𝐷𝐼𝑣𝑜𝑙
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The conversion coefficient factor used in this equation is obtained according to the
𝑖

𝑧
100
|〈𝑖〉 is the corrected CTDIvol at average
effective diameter of center slice and <𝑖>
𝐶𝑇𝐷𝐼𝑣𝑜𝑙
𝐿

current (average CTDIvol).
Based on equation (25) for a single scan the CTDIvol and current of each image on a sliceby-slice base are collected. Then the data are plotted using CTDIvol versus current for all
slices to find the linear relationship between CTDIvol and current for the entire scan for
one patient. The average current of entire CT scan can be obtained in tag header by average
the currents of all slices. Then the average CTDIvol can be obtained. For modulated CT
scan the current of each slice is different. However, other parameters are maintained same,
such as voltage and rotation speed during the entire CT scan. Then the average CTDIvol at
average current can be calculated by using average current following the equation (24).
The conversion coefficient is obtained from only the center slice of a series of slices in the
entire CT scan. The anterior-posterior dimension diameter and the lateral dimension
diameter are measured manually from the center slice in ImageJ by converting from pixel
numbers. Then the effective diameter of the center slice can be used for the calculation of
conversion coefficient for the center slice (equations (17) and (18) for different regions).
Following equation (25) the SSDE of the patient will be obtained by using our proposal
SSDE approach.
Two SSDE results of the same patients by alternative average SSDE approach (AAPM,
TG220, 2015) and average CTDIvol approach (the proposal approach) then will be
compared based on abdomen CT scan 20 patients’ data at St. Vincent’s Hospital in 2016.
After the SSDE results based on proposal approach (equation (25)) and different
58

dimensional diameters of center slices of abdomen CT scan data of 100 patients at St.
Vincent’s Hospital in 2016 have been obtained and compared, the relationship between
CTDIvol and different dimensional diameters of center slice and the relationship between
SSDE and CTDIvol will be examined.

3.3 Skin dose measurements of CT scan with an anthropomorphic
phantom
The aims of this investigation were two-fold: firstly, explore the effects of TCM on skin
dose when compared to non-TCM and. Secondly, study the impact of transaxial patient size
on the skin dose.
3.3.1 Materials
CT scanners
The CT scanners considered were the 320-slice TOSHIBA Aquilion ONE Helical CT
(Software Version V6.06ER004, bore size 72cm, maximum 140 kV, min slice thickness
0.5mm) and the 128-slice PHILIPS Ingenuity helical CT (maximum 140 kV, min slice
thickness 0.625 mm, bore size 70cm).
Phantom
The Alderson Radiation Therapy (ART) phantom is tissue-equivalent that includes bone,
lung and soft tissue of compositions as specified. The male chest and abdomen ART
phantom shown in Figure 7, is made of 17 2.5 cm thick slices (numbered from 10-shoulder
to 27-pelvis) a total height of 45 cm. each section has multiple 5 mm diameters cylindrical
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holes that allow the insert of bone-equivalent, or lung-equivalent pins depending on section
location. In this study, only the surface dose of the phantom was measured in abdominal
region.

1

2

3

4

5

→→→scanning direction

Figure 9 The anthropomorphic phantom (male adult chest and abdomen)

In this study only the abdominal region was the interest region therefore the tissueequivalent pins for other regions have not been used. Five scan region targets of abdomen
from slice 19-27 and the related effective diameters are shown in Table 4.
Table 4 Five measurement points’ locations and effective diameters (see Figure 9)
Measurement points

slice number (location)

Effective diameter (cm) +-0.1
cm

1

19

27.5

2

21

26.6

3

23

25.5

4

25

25.2

5

27

25.8
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The phantom is in the isocentre of the scanner, head first, supine. Practically, the positions
were reproducible positions. In table 4 measurement point 1 represents the widest region of
the phantom located towards the chest, whilst the measurement point 4 represents the
thinner region of the phantom towards the phantom hips. The measurement point 5 is the
last slice of the phantom (slice number 27). The CT scans of the phantom covered a length
of 25 cm from slice 18-27 or a length of 35 cm from slice 14 to slice 27. The location of the
measurement points’ were fixed for both scanning length (25 cm and 35 cm).
MOSkin dosimeter
The MOSkin detector, including the case, is 30.0 cm long and 2.5 cm wide with an overall
thickness of about 0.4 mm. On one end is the silicon radiation sensor with 0.8 mm x 0.6mm
x 0.35 mm size. In the sensor the submicron gate oxide thickness is 0.55µm on the other
end of the MOSkin detector the connector pins connects the cables for in vivo readout with
the MOSkin reader.

Figure 10 The CMRP MOSkin dosimeter used for the CT dose measurement (Pei Ling, 2012)

The threshold voltage difference (before and after the irradiation) is proportional to the
accumulated dose. The change in threshold voltage was measured with a portable MOSkin
reader, the clinical Semiconductor Dosimetry System (CSDS) designed and calibrated by
the CMRP at the University of Wollongong. Figure 10 shows the CSDS reader which
allows 5 MOSkin dosimeters to be readout simultaneously. The reader can apply a
maximum gate voltage of 15 V during irradiation to separate the charge pairs produced in
the oxide.
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Figure 11 The Clinical Semiconductor Dosimetry System (CSDS) reader system for MOSkin (Pei
Ling, 2012).

3.3.2 TCM impact and size impact on phantom skin dose
The scanning protocols
The scanning protocols were based on clinical patients’ protocols recorded from 2007 to
2016 for abdo-pelvis region. TCM model will be on first for the phantom scan to obtain the
basic CT parameters for both the Philips system CT and Toshiba system CT. Then the
average current will be set as the current for non-TCM model situation for same CT system
respectively. Then the results with different scanning lengths (25 cm vs. 35 cm) will be
compared. The CT scanner protocols used in this experiment are shown in Table 5 below
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Table 5 The abdomen-pelvis scan protocols for the Philips and Toshiba CT scanners

kVp

CT scanner
Philips
Toshiba
TCM
NON-TCM
TCM
NON-TCM
120
120
120
120

Current (mA)

150-156

152

150-287

290

Exposure time (mS)

500

500

500

500

Scan length (cm)

25/35

25/35

25/35

25/35

pitch

0.797

0.797

0.828

0.828

Collimation Width (mm)

0.625x64

0.625x64

0.5x64

0.5x64

Slice thickness (mm)

4

4

4

4

MOSkin dosimeters setup
Only the abdominal region’s surface dose will be examined with 25-35 cm scanning length.
Five scan targets of abdomen have been selected along axial scanning direction. Five
MOSkin dosimeters will be taped vertically against scan plane/phantom on the surface of
the five points. The MOSkin dosimeters are connected with the CSDS MOSkin readers.
The reading values will be shown with unit of mV, which is the threshold voltage
difference between before and after the irradiation on semiconductor. The five points’
doses can be obtained by the MOSkin readers’ readings divided by the calibration factor.
Each point will be measured five times and the averaged value will be the final point dose.
The MOSkin dosimeters’ setups on the phantom are shown below. The calibration factor is
7.5 mV/cGY with error 0.13 (1%) which was referenced from Centre of Medical Radiation
Physics, University of Wollongong. The dose sensitivity was 7.2 mV/cGy to 7.9 mV/cGy
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during re-irradiation. Within a time interval of 240 s, the percentage fading of the MOSkin
reading was less than 1%.

Figure 12 Screenshot of five MOSkin dosimeters which were taped on surfaces of the five points
(Figure 9) on phantom along axial scanning direction.
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Chapter 4 Results and Discussions

In this chapter the results will be presented in three sections: the first will refer to the CT
dose level trends at St. Vincent’s Hospital (Facility Diagnostic Reference Levels, FDRLs
including CTDIvol and DLP) by current ARPANSA approach for four regions (chest, head,
abdomen and chest + abdomen + pelvis (CAP)) and comparison with Australian NDRLs
(2011, see Table 1). The second part will compare the AAPM SSDE average approach with
the average CTDIvol approach on patient data. The third part will present the skin dose
evaluation of TCM and impact of transverse size on anthropomorphic phantom using
MOSkin dosimeters.

4.1 CT dose trends at St. Vincent’s Hospital in last ten years from 2007 to
2016
4.1.1 Abdomen
CTDIvol
Figure 11 shows the obtained year-to-year CT dose levels of FDRL CTDIvols from
abdominal MDCT scans at St. Vincent’s Hospital in the time period of 2007-2016.
Significant dose level rising was occurred in 2010 and 2011 with CTDIvols of 17.85mGy
and 18.50 mGy respectively, which are significantly higher than the Australian NDRLs of
15 mGy. These rises were mainly due to the St. Vincent’s Hospital MDCT facility upgrade
from the Philips Brilliance CT system (64 slices) to the Toshiba Aquilion One system (320
slices) in 2010, shown in Table 6. Keeping a similar CT scan protocol, the 320-slice
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Toshiba MDCT system resulted in significant higher CT dose levels than the 64-slice
Philips Brilliance CT system. By reducing the exposure factor of mAs, the dose levels in
2012 and 2013 went back under the Australian NBDRLs again. Since 2014, the dose
reduction technique with tube current modulation (TCM) has been utilized in the routine
CT examinations at St. Vincent’s Hospital has been with a 128-slice Philips Brilliance CT
system. Although the exposure factor of kVp was reduced from 120 to 100 and the mAs
were doubled, the CT dose levels still remained under the Australian NDRLs.
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Figure 13 Bar graph of the FDRL CTDIvols of abdominal MDCT scans from 2007 to 2016 at St.
Vincent’s Hospital. The red line denotes the Australian NDRL of 15 mGy in CTDIvol for the
abdomen CT examinations. The dash lines represented the maximum and minimum CTDIvols
respectively in each year of the 20 patients considered.

The dash lines in the figure can only show the maximum and minimum CTDIvol values
however the results did not show the numbers of the patients who had lower or higher
CTDIvol values than DRL in each year. Therefore, in Figure 14 the CTDIvol distribution in
term of percentages of patients has been shown for each year.
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Table 6 The comparison of CT parameters and CTDIvols of abdomen CT scan at St. Vincent’s
Hospital from 2007 to 2016 on both Philips and Toshiba CT scanner. The second rows in average
exposure and CTDIvol are variations. Philips Brilliance 64 (non-TCM) has been used between
2007-2009, Toshiba Aquilion One 320 (non-TCM) has been used between 2010-2013 and Philips
Brilliance 128 (TCM) has been used after 2013.

2007
CT system

Voltage

2008

2009

2010

2011

2012

2013

2014

2015

2016

Philips Brilliance 64

Toshiba Aquilion One 320

Philips Brilliance 128

(non-TCM)

(non-TCM)

(TCM)

120

120

120

120

120

120

120

100

100

100

104.167

103.571

104.546

107.400

128.692

99.167

84.941

223.208

211.662

238.145

0

0

0

36.433

124.439

95.013

171.428

139.124

67.659

90.383

0.859

0.859

0.859

0.828

0.828

0.828

0.828

0.984

1.047

0.961

5.900

5.900

5.981

17.850

18.500

11.300

9.100

12.701

8.901

8.753

0

0

0

6.312

4.887

3.209

2.055

4.417

3.063

2.641

(kVp)
Average
Exposure
(mAs)
Pitch (set
value)
Facility
CTDIvol
(mGy)

The presentation of CT scanner statistics of CTDIvol data from the selected 200 patients
who received abdomen MDCT scans at St. Vincent’s Hospital in 2007-2016. In the table 6
the variations of exposure and CTDIvol showed exactly the St. Vincent’s protocols changes
mentioned above. The integral CTDIvol distribution is shown in Figure 14. The plot
displayed the percentage of patients in the abdomen scans that achieved a facility reference
level above the CTDIvol specified on the x-axis.
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Figure 14 The integral CTDIvol distribution in term of percentages of patients from 200 patients
who received abdomen MDCT scans at St. Vincent Hospital from 2007 to 2016. The red line
denotes the Australian NDRL of 15 mGy in CTDIvol.

From Figure 14 there are about 15% (30 out of 200 patients) abdomen MDCT scans with
CTDIvols beyond the Australian NDRL. This means that 85% abdominal MDCT scan
patients at St. Vincent’s Hospital had CTDIvols under the Australian NDRL from 2007 to
2016. The 30 patients who had high CTDIvol levels are 11 patients in 2010, 12 patients in
2011, 5 patients in 2012 and 2 patients in 2013.
DLP
Figure 15 shows the obtained year-to-year CT dose levels of DLPs from abdominal MDCT
examinations at St. Vincent’s Hospital in 2007-2016. The year-to-year DLP variations
show the very similar trend as the CTDIvols.
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Figure 15 Bar graph of the FDRL DLPs of abdominal MDCT scans from 2007 to 2016 at St.
Vincent’s Hospital. The red line denotes the Australian national DRL of 700 mGy.cm for the
abdomen CT examinations. The dash lines represented the maximum and minimum DLPs
respectively in each year for the 20 patients considered.

In Figure 15 the abdomen MDCT scans’ FDRL DLPs except 2011 (714.8 mGy.cm) were
inside the NDRL (700.0 mGy.cm). The same increasing trend from 2009 to 2013 still can
be seen. From 2014 to 2016 the DLPs were all under the NDRLs which were similar with
the CTDIvols results though the exposure levels were higher than 2007-2013 significantly.
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Figure 16 The integral DLPs distribution in term of percentages of patients from 200 patients who
received abdomen MDCT scans at St. Vincent Hospital from 2007 to 2016. The red line denotes the
Australian NDRL of 700 mGy.cm in DLP.

In Figure 16 the percentage of abdomen MDCT scan patients with DLPs above the
Australian national DRL was 16.5% (33 out of 200 patients) at St. Vincent’s Hospital from
2007 to 2016. These 33 patients included 10 patients in 2010, 10 patients in 2011, 7
patients in 2012, 3 patients in 2013 and 3 patients in 2014.
In our study the FDRLs of abdominal CT scan were higher than that of chest and CAP
regions but lower than head region, which is the same with NDRLs. The abdominal
scanning needs more photons to be penetrated through different organs to obtain high
quality images, which caused the scan protocols changes. Therefore, the current was
generally higher than other three regions. However, some contribution factors should be
considered as well. Other potential contributions can be: excessive scan ranges, for example,
the chest or pelvis scanning were additionally acquired during abdominal scan; equipment
factors can contribute to the scanning dose index significantly, such as manufacturing
factors. For example, the abdominal-only scan can have the same CTDIvol with
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abdominal/pelvis scan but abdominal/pelvis scan can have higher DLP than abdominalonly scan due to longer scan length following the DLP and CTDIvol calculation. Therefore,
the higher image quality can cause higher dose.
4.1.2 Chest
CTDIvol
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Figure 17 Bar graph of the FDRL CTDIvols of chest MDCT scans from 2007 to 2016 at St.
Vincent’s Hospital. The red line denotes the Australian national DRL of 15 mGy for the chest CT
examinations. The dash lines represented the maximum and minimum CTDIvols respectively in
each year for the 20 patients considered.

In Figure 17 2007-2016 chest MDCT CTDIvol results at St. Vincent’s Hospital showed
that all the FDRL CTDIvols of chest CT scans from 2007 to 2016 were under the
ARPANSA (2011) Australian NDRL. The highest level of CTDIvol was in 2011 (13.8
mGy) and there was a high point in 2010 (13.6 mGy). The same results with the FDRLs of
abdominal CT scan, which was that the CTDIvols of 2014-2016 were still under the
NDRLs even with higher exposure than 2007-2013 and lower voltage. The percentages of
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patients who received chest scan CTDIvols above and below the Australian national

Percentage of Patients %

diagnostic reference level are investigated.
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Figure 18 The integral CTDIvols distribution in term of percentages of patients from 200 patients
who received chest MDCT scans at St. Vincent Hospital from 2007 to 2016. The red line denotes
the Australian NDRL of 15 mGy in CTDIvol.

In Figure 18 the Australian national DRL of chest MDCT scan CTDIvol is 15 mGy and the
percentage of patients whose chest MDCT scan CTDIvols were above the national
reference level at St. Vincent’s Hospital was 3% (6 out of 200 patients) in last ten years
(2007-2016). These 6 patients were including 83% (5 patients) in 2011 and 17% (1 patient)
in 2010, which were the protocol adjustment period.
DLP
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Figure 19 Bar graph of the FDRL DLPs of chest MDCT scans from 2007 to 2016 at St. Vincent’s
Hospital. The red line denotes the Australian national DRL of 450 mGy.cm in DLP for the chest CT
examinations. The dash lines represented the maximum and minimum DLPs respectively in each
year for the 20 patients considered.

From the graph the FDRL DLPs of chest MDCT scans from 2007 to 2016 at St. Vincent’s
Hospital were all under the national reference level. Similar with CTDIvol, there was a
highest level in 2011 and a significant drop in 2012. The DLPs of 2014-2016 were all under
NDRLS.
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Figure 20 The integral DLPs distribution in term of percentages of patients from 200 patients who
received chest MDCT scans at St. Vincent Hospital from 2007 to 2016. The red line denotes the
Australian NDRL of 450 mGy.cm in DLP.

In the graph the Australian national reference level of chest MDCT scan DLP is 450
mGy.cm and the percentage of patients whose chest MDCT scan DLPs were above the
national DRL in St. Vincent’s Hospital was 6.5% (13 out of 200 patients) in 2007 to 2016.
These 13 patients included 9 patients (70%) in 2011 and 4 patients (30%) in 2010.
In our study the clinical results showed that there were higher levels of FDRLs in the time
period of 2009-2013. The anatomical difference of chest region can contribute to the results
as well. The chest region is different with other regions anatomically. This region includes
lungs which are filled with more air than other regions. Therefore, the attenuation will be
smaller. Based on tube current modulation model the current for chest scanning will be
smaller than other regions and the collimation will be smaller to detect small lesions. The
rotation will be faster to reduce the artefacts caused by body motion of breathing. The pitch
should not be too small or too large due to the small exposure. If the pitch is too small more
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doses will be received by patients. If the pitch is too big the small fine lesions cannot be
detected properly.
4.1.3 Head
CTDIvol
The FDRL CTDIvols of head MDCT scans from 2007 to 2016 at St. Vincent’s Hospital
were investigated.
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Figure 21 Bar graph of the FDRL CTDIvols of head MDCT scans from 2007 to 2016 at St.
Vincent’s Hospital. The red line denotes the Australian national DRL of 60 mGy in CTDIvol for the
head CT examinations. The dash lines represented the maximum and minimum CTDIvols
respectively in each year for the 10 patients considered.

In the figure all the FDRL CTDIvols of head MDCT scans from 2007 to 2016 were below
the national reference level and there was no significant fluctuation however, an increasing
trend from 2009 to 2013 still can be seen. There was another relatively high point in 2008
(54.50 mGy) due to the highest exposure time in 2008 (1.73 s) than other years. For head
region the CT doses from 2014 to 2016 were all under the NDRL as abdomen and chest
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regions. The percentage of patients who received head scan and relevant CTDIvols were
investigated.
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Figure 22 The integral CTDIvols distribution in term of percentages of patients from 100 patients
who received chest MDCT scans at St. Vincent Hospital from 2007 to 2016. The red line denotes
the Australian NDRL of 60 mGy in CTDIvol.

In the graph the percentage of head MDCT scan patients with CTDIvols above Australian
national DRL was 0% at St. Vincent’s Hospital from 2007 to 2016. All the patients’ head
MDCT CTDIvols were inside the Australian national reference level.
DLP
The FDRL DLPs of head MDCT scans from 2007 to 2016 at St. Vincent’s Hospital were
calculated.
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Figure 23 Bar graph of the FDRL DLPs of head MDCT scans from 2007 to 2016 at St. Vincent’s
Hospital. The red line denotes the Australian national DRL of 1000 mGy.cm in DLP for the head
CT examinations. The dash lines represented the maximum and minimum DLPs respectively in each
year for the 10 patients considered.

In the graph the FDRL DLPs of head MDCT scan from 2007 to 2016 were all under the
NDRL and there was a highest level in 2011 after an increasing trend from 2009 to 2011
similar with that in other regions.
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Figure 24 The integral DLPs distribution in term of percentages of patients from 100 patients who
received head MDCT scans at St. Vincent Hospital from 2007 to 2016. The red line denotes the
Australian NDRL of 1000 mGy.cm in DLP.

The Australian national DRL is 1000 mGy.cm for MDCT head scan DLP. The percentage
of brain MDCT scan patients whose brain MDCT scan DLPs above 1000 mGy.cm was 0%
at St. Vincent Hospital between 2007 and 2016.
In our clinical results the head CT FDRLs trends were more stable and higher than other
regions. The issue for head CT scan is that the CTDI of each point of head is not
significantly different as that of other parts of the body (Boone, 2007) and cannot affect the
CTDIvol calculation though CTDI is calculated by the combination of centre and periphery
points’ dose estimations. As a result, the CTDI values of head CT scanning are more stable
than other parts of human body scanning. The anatomical significance of head is that the
head is mostly covered by dense bones and therefore has less fluctuation of attenuation and
the current of scanning will not change significantly following tube current modulation
model. The relatively small scan length of head compared with other regions of the body
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can contribute to the stable DLP values as well. At same time due to the high attenuation of
bone the CTDIvol value is higher than other regions.
4.1.4 Chest-abdomen-pelvis (CAP)
CTDIvol
The FDRL CTDIvols of chest-abdomen-pelvis (CAP) MDCT scan patients from 2007 to
2016 at St. Vincent’s Hospital were investigated.
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Figure 25 Bar graph of the FDRL CTDIvols of CAP MDCT scans from 2007 to 2016 at St.
Vincent’s Hospital. The red line denotes the Australian national DRL of 30 mGy in CTDIvol for the
CAP CT examinations. The dash lines represented the maximum and minimum CTDIvols
respectively in each year for the 20 patients considered.

From the graph all the FDRL CTDIvols of CAP MDCT scan patients from 2007 to 2016
were significantly lower than the national reference level. Even the highest level in 2013
(10.68 mGy) was 64.41% lower than the national reference level. However, the same
increasing trend from 2009 to 2013 still can be seen. The CTDIvols from 2014 to 2016
were still under the NDRL as other regions.
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Figure 26 The integral CTDIvols distribution in term of percentages of patients from 200 patients
who received CAP MDCT scans at St. Vincent Hospital from 2007 to 2016. The red line denotes the
Australian NDRL of 30 mGy in CTDIvol.

In Figure 26 the percentage of CAP MDCT scan patients who received CTDIvols above
Australian national DRL was 0% at St. Vincent’s Hospital in last ten years from 2007 to
2016. 100% of CAP MDCT scan patients had CTDIvols inside the Australian national
reference level in last ten years.
DLP
The FDRL DLPs of chest-abdomen-pelvis MDCT scan patients from 2007 to 2016 at St.
Vincent’s Hospital were calculated.
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Figure 27 Bar graph of the FDRL DLPs of CAP MDCT scans from 2007 to 2016 at St. Vincent’s
Hospital. The red line denotes the Australian national DRL of 1200 mGy.cm in DLP for the CAP
CT examinations. The dash lines represented the maximum and minimum DLPs respectively in each
year for the 20 patients considered.

Similarly, the FDRL DLPs of chest-abdomen-pelvis MDCT scans were significantly lower
than the national reference level. The same increasing trend from 2009 to 2013 still can be
seen. The DLPs of 2014-2016 were all under the NDRL with doubled exposure than that of
the CT scanning in 2007-2013. Then after comparing the percentages of CAP MDCT scan
patients with related DLPs, the results were shown in Figure 26.
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Figure 28 The integral DLPs distribution in term of percentages of patients from 200 patients who
received CAP MDCT scans at St. Vincent Hospital from 2007 to 2016. The red line denotes the
Australian NDRL of 1200 mGy.cm in DLP.

In Figure 28 the results showed that 4% (8 out of 200 patients) CAP MDCT scan patients’
DLPs were above the Australian national DRL at St. Vincent’s Hospital in the last ten years
(2007-2016). 96% patients’ CAP MDCT scan DLPs were inside the Australian national
reference level in the last ten years. These 8 patients who had higher DLPs included 3
patients in 2012, 4 patients in 2013 and 1 patient in 2014.
In our study the chest-abdominal-pelvis MDCT FDRLs at St. Vincent’s Hospital from 2007
to 2016 were significantly lower than ARPANSA references. The only difference between
CAP region and other three regions is size difference. The CAP region crosses three
regions, chest, abdomen and pelvis, which causes a significant size information fluctuation.
Therefore, the CAP region cannot be represented by a standardized 32 cm diameter
phantom. In our study case most patients who received CT scan in the last ten years at St.
Vincent’s Hospital were aged people (the samples’ ages were between 20 to 98 years old,
and young adults, 20-35, are only 10% to 20%) with aged related diseases which can affect
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the tissue attenuation. Another issue is the anatomical over-lap. In current ARPANSA
DRLs table the CAP region reference levels are the sum of chest region reference level and
abdomen + pelvis region reference level. Therefore, if anatomical over-lap has been taken
into account, the connection of body parts between chest and abdomen will be double
calculated, such as upper abdomen and lower chest. In other words, the current NDRLs of
CAP regions are dose overestimated. Therefore, the significant results of CAP region may
be due to the size effect and/or due to the dose over-estimation of current NDRLs.
In a summary based on the results the CT scanning protocols play important roles on CT
dose estimations. The higher current, voltage, exposure time, scanning area selection and
Non-TCM scanning contribute to higher CT dose estimation directly. To maintain a
balance between image quality and patient dose would enlarge the benefit of CT scanning.
The clinicians must follow the standard protocol and ALARA principle and if a patient had
higher CTDIvol value or DLP value than NDRL, the CT parameters should be reviewed
following a logical relationship between each other. The FDRLs should be constantly
reviewed and reported. Another important contributing factor is the technology update,
such as TCM technology.

4.2 Estimations of patient size impacts using SSDE
4.2.1 SSDE Results of alternative AAPM approach (average SSDE)
Figure 29 shows comparison between SSDE and CTDIvol (average SSDE and average
CTDIvol of each patient) for patient size impacts from 20 patients in abdomen MDCT
examinations at St. Vincent’s Hospital in 2016. As expected, larger variations (error bars)
among patients are observed in the SSDEs (0.9-1.9 mGy) but smaller variations are shown
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in CTDIvols (0.4-1.3 mGy) since CTDIvol does not account for the patient size effects
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Figure 29 20 abdomen MDCT scan patients’ SSDEs and CTDIvols in 2016. The error bars are
standard deviation of SSDEs.

Patient 3 and 5 had highly similar CT parameters and CTDIvol but different size. Therefore,
the related SSDEs are supposed to be different. After the combination of CT parameters,
CTDIvol values and related SSDEs of the patient 3 and the patient 5, results were compared
and shown exactly that they were supposed to be (see Table 7).
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Table 7 The comparison of CT parameters, CTDIvols, effective diameters and SSDEs of patients 3
and 5 who had abdomen CT scan in 2016 at St. Vincent’s Hospital
patient

3

5

Exposure (mAs)

236.88

236.88

pitch

0.891

0.891

Potential (kVp)

100

100

window center

40/40

40/40

CT system

Philips

Philips

effective diameter (cm)

26.02

29.91

CTDIvol (mGy)

9.32

9.28

SSDE (mGy)

14.72

12.42

In the table the parameters (Philips system) of two patients were same therefore, the
CTDIvol values are similar. Patient 5 and patient 3 had similar CTDIvol however, patient 3
had smaller size. As a result the SSDE of patient 3 was larger than the SSDE of patient 5.
Based on CTDIvol values these two patients had similar CT dose estimations however,
actually patient 3 had more doses than patient 5 due to the small size. Because of small size
of some patients or paediatric patients, the size information must be considered and the
exposure should be reduced or the pitch factor should be increased for small size patients
otherwise the patient’s dose will be underestimated.
Then the samples were enlarged to 100 patients who received abdomen MDCT scan at St.
Vincent’s Hospital in 2016 and, the SSDE and the CTDIvol results were compared again to
minimize the small sample’s bias.
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Figure 30 The SSDEs of 100 abdomen CT scan patients in 2016 at St. Vincent’s Hospital
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Figure 31 The CTDIvols of 100 abdomen CT scan patients in 2016 at St. Vincent Hospital

The 100 abdomen CT scan results showed similarity with that of 20 abdomen CT scan,
which is that SSDEs were variated with the changes of the effective diameters (correlation
0.67) than CTDIvols (correlation 0.27) due to the size effect on patient’s CT dose
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estimations, which is that the dose estimations are increasing with the increase of the
scanned size. The similar results were shown in chess and abdomen regions as well.
Furthermore, the relationship between SSDE and CTDIvol has been examined for 100
abdomen CT scan patients in 2016 as well.
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Figure 32 The relationship between SSDEs and CTDIvols of 100 abdomen CT scan patients at St.
Vincent’s Hospital in 2016

The results showed that with the increase of CTDIvol there was a logarithmic change of
SSDE (R square 0.76) for abdomen CT scan. The SSDE was calculated by CTDIvol
followed the equation (19) therefore the SSDE increases with the increase of CTDIvol.
Other regions the SSDEs vs. CTDIvols results were shown in Figure 31.
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Figure 33 The chest CT scan SSDEs and CTDIvols of 20 patients in 2016
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Figure 34 The chest CT scan SSDEs and effective diameters of 20 patients in 2016
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Figure 35 The head CT scan SSDEs and CTDIvols of 20 patients in 2016
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Figure 36 The head CT scan SSDE vs. effective diameter of 20 patients in 2016.

The SSDEs and CTDIvols of head region CT scan did not show fluctuation as other regions
due to the small variation of CTDIvol. In the conversion factor table (see APPENDIX C)
most of the adult head conversion factors are less than one therefore the SSDEs here were
smaller than CTDIvols. Therefore, the SSDE vs effective diameter figure showed a line due

89

to the small size difference (1.9 cm) between each size which is very small compared with
other three regions (25.9cm for abdomen, 17.7 cm for chess, 9.1 cm for chess).
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Figure 37 The CAP CT scans SSDEs and CTDIvols of 20 patients in 2016.
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Figure 38 The SSDEs and effective diameters of CAP CT scan

From Figure 33 to Figure 38 the SSDEs were showed more small fluctuations than the
CTDIvols of these regions, which are similar with abdomen CT scan results. The variations
of SSDE against CTDIvol showed that the CAP (3.70 mGy) and the chest (3.68 mGy)
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regions have larger variations than the abdomen region (3.13 mGy) and head (2.66 mGy)
region. The CAP region and the chest region have different attenuation tissues, such as lung
and intestines then the attenuations will be significantly different between air-fill tissue and
non-air-fill tissues. The CAP region is including chest region therefore, the variations of
CAP and chest are not significantly different. The head region has high attenuation
however small attenuation fluctuation therefore, small SSDE variation.
In a summary in AAPM (TG 204, 2011; TG 220, 2015) SSDE has been described as that
the average CTDIvol in the center of dose profile spreads along the scanning length, which
means that the SSDE results can be higher than CTDIvol because in the center of the dose
profile the dose is higher than that in the tails. The reason is that the average CTDIvol of
the center of the dose profile is higher than the average CTDIvol of the center and the tails
of the dose profile. In other words, CTDIvol and DLP maybe underestimate patient CT
dose without size information. The variations (error bars) of SSDE results showed higher
than CTDIvols from all the results which means that the SSDE has taken the size variations
into account therefore, dose estimations are close to the real patient dose. The head region
CT scan result is different due to the high uniformity and small variations of size in head
region (see head region DRLs discussion).
Our study results based on clinical patients’ data suggested that the CTDIvol and DLP
underestimated patient dose in abdomen, chest and CAP region. In Table 7 the results
showed that CTDIvol has limitation on presentation of patient dose estimation due to the
missing of size information.
4.2.2 Comparison between AAPM approach and proposed approach SSDE results
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The average CTDIvol was obtained by using the method mentioned above and the results
of patients (16, 7 and 20) of abdomen CT scan in 2016 were calculated.
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Figure 39 The patient 16’s CTDIvol against current of each image. The CTDIvol and the current of
each image were from header tag information. The average current of all the images was
calculated then the average CTDIvol was obtained.
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Figure 40 The patient 7’s CTDIvol against current of each image. The CTDIvol and the current of
each image were from header tag information.
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Figure 41 The patient 20’s CTDIvol against current of each image. The CTDIvol and the current of
each image were from header tag information.

The CTDIvol was showed a linear relationship against current which is exactly the
relationship between estimated dose and the photon numbers. Furthermore, the variations
of CTDIvol were generally lower than SSDEs’ shown in Figure 31, 34, 36 and 38 due to
the size information missing when estimate the patient dose (CAP 1.42 mGy, chest 1.73
mGy, abdomen 0.66 mGy and head 0 mGy) however, the CTDIvol variations trend still
followed the same trend of SSDE variations. The size information can reflect the tissue
attenuation difference and then the current variated based on the tissue attenuation. As the
result the patient CT dose estimation will be variated. Therefore, the SSDE results
variations were larger than CTDIvol results due to the size information considerations. The
SSDEs of proposal approach in this study were calculated for the same abdomen MDCT
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scan patients who had the SSDE calculations by AAPM approach at St. Vincent’s Hospital
in 2016. The results were compared and the correlation between two approaches’ results

SSDEs and CTDIvols (mGy)

has been tested.
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Figure 42 The comparison between the SSDEs calculated by AAPM (average SSDE) approach and
that calculated by proposal (average CTDIvol) approach. Same 20 samples of abdomen CT scan in
2016 at St. Vincent’s Hospital were used for both approaches.

The results showed that the two sets of SSDE results by AAPM approach and by proposal
approach were not significantly different. The correlation t-test results showed that the
correlation between the results by two SSDE approaches were 0.98 with a significance of
p ≪ 0.001. Therefore, two SSDE results by AAPM approach and by proposal approach
showed high agreement in this case. On the other hand, both of the SSDE results by
different approaches were higher than CTDIvol obtained from current.
Limitations of the current experimental verification
In a summary the AAPM approach is conducted in a time-consuming way. For example, a
patient had a 200-slice CT scan and the measurement of the dimension diameter will be 200
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times. At the same time the measurement error increases with the increase of the slice
numbers. However, the proposed average CTDIvol approach only need measure the
dimensional diameters in center slice, which is time saving and reduces the measurement
error. Therefore, the SSDE results may be closer to the real patient’s dose.
However, the limitations of the proposal SSDE approach are still significant. Firstly, both
of SSDE measurement approaches (AAPM approach and proposal approach) are limited to
estimating patient dose using CTDIvol of CT scanner output and the conversion factor
related with patient size. Therefore, the SSDE measurement is actually the size-corrected
CTDIvol based on 16 cm and 32 cm uniform phantoms, which can result a uniform-like
attenuation. In reality the CT scanning on a real patient the attenuation will be non-uniform.
Therefore, more patient-representative phantoms should be more accurate for patient dose
estimates measurement. The geometric size metrics were still used as the effective diameter
as a surrogate for the x-ray attenuation rather than the attenuation metrics recommended in
AAPM Task Group 220 (2015) therefore the SSDE results will be less accurate to patient
real dose estimation as that indicated before. Furthermore, the SSDE measurement cannot
represent the organ dose.
Secondly, the SSDE measurement is determined based on the average dose at the center of
the scanned region (z direction). Therefore, the value is slightly higher than the average
dose over the entire scanned tissue volume due to less doses of tails compared with the
center dose of dose profile. AAPM (2011) mentioned that the dose is lower at the beginning
of the scanned volume, increases to a peak at the center of the scanned volume and drops at
the end of the scanned volume. The results in Figure 36 proved exactly this theory by the
small difference between AAPM SSDE approach and our proposed SSDE approach results.
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Thirdly, the patient dimensional measurement may have error due to the manual measuring
from the patient CT images. Though the dimension measurement is taken in ImageJ and
converted by the pixel number it still depends on the distance between patient and the x-ray
source, and the manual measurement error still can occur.
The proposed SSDE approach in this study has disadvantages and advantages mentioned as
above. Therefore, further studies are needed to achieve better statistics and validation. It is
hopeful that our proposal SSDE approach can indicate a useful suggestion or direction for
future researchers in informing national DRLs, guidelines, department protocol, the gains
for patients and future patients when increased accuracy of dose estimate is available, more
realistic guidelines can be applied and exposure optimized..

4.3 Skin dose evaluation of TCM and size impacts on anthropomorphic
phantom
4.3.1 TCM impact on phantom skin dose

Figure 43 The images scanned under TCM and non-TCM (CT abdominal scan, the left is with TCM
Standard Deviation (SD)=10, the right is with non-TCM, SD=8) of Toshiba scanner on phantom.
The larger SD value reflected the high noise with low image quality, which can be reflected on the
black dots.
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The same region scanning images under TCM and Non-TCM showed acceptable quality.
The slice under TCM had only 180 mA with 9.20 mGy CTDIvol while the slice under NonTCM had 290 mA current with 17.91 mGy CTDIvol. As a result, the scan under TCM
reduced 14%-49% dose estimation (CTDIvol) than that under Non-TCM with significant
current difference (110 mA) with a limit noise index increase. Therefore the medical
imaging staff should maintain the balance effectively between the image quality and the
patient dose. From the definition of noise index (SD of CT numbers) which is proportional
to the reverse of the square root of the dose, the noise index increases then the image noise
increases and the CTDIvol and patient dose decrease.
Furthermore, the CTDIvol and SSDE were compared with the skin dose results based on
MOSkin dosimeter’s measurements of five different measurement points (see Table 4)

97

Table 8 The comparisons between CTDIvol and SSDE respectively and skin dose obtained from
MOSkin dosimeters on phantom
MOSkin position
Effective diameter (cm)

1
27.5

2
26.6

3
25.5

4
25.2

5
25.8

uncertainty
0.9

TCM

15.40

10.60

9.20

9.10

9.11

1.18

NonTCM

17.91

17.92

17.90

17.91

17.92

0.01

TCM

22.04

15.65

14.15

14.42

13.87

1.74

NonTCM

23.63

24.52

26.49

26.49

25.60

0.26

Skin Dose
measured
from
MOSkin
(mGy)

TCM

13.47

13.07

10.67

10.67

9.20

1.80

NonTCM

17.73

20.8

20.53

20.27

17.47

1.60

Noise Index
(SD)

TCM

10.0

NonTCM

8.0

CTDIvol
(mGy)

SSDE (mGy)

In the table TCM impact on CTDIvol and SSDE was significant, which is that both
CTDIvol and SSDE of non-TCM scanning were higher than those of TCM scanning. The
CTDIvols of non-TCM scanning were same due to that the CTDIvols were averaged by CT
system based on one size standard phantom (32 cm for abdomen) under same current. The
CTDIvols of TCM scanning were different due to that the current was modulated therefore
the size information has been reflected. The uncertainties of TCM results were higher than
that of non-TCM results which showed the TCM impact with significant variations. The
CTDIvols, SSDEs and doses of TCM scanning fluctuated more significantly than those of
non-TCM scanning. From table results the CT dose reduction impact is significant with a
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slight increase of Noise Index, which is the standard deviation of the attenuation. Higher
Noise Index means low image quality.
The skin dose results have been compared between TCM and non-TCM scanning on both
Toshiba and Philips CT scanner and the results were investigated.
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Figure 44 The skin doses comparison under TCM and non-TCM on phantom under 25 cm scanning
length. The size values are in an order of the smallest to the largest which represented the
measurement points on phantom in an order of 4, 3, 5, 2, 1 (see Table 4 & Figure 9). The scanning
start point is point 1 of chest and the scanning end point is point 5 of pelvis on phantom.

The results showed that the skin doses in non-TCM scanning were higher (average 29.3%)
than those in TCM scanning. However, due to the consideration of significant current
difference of the 25.5 cm point (150 mA in non-TCM scanning and 71 mA in TCM
scanning), the significant skin dose difference between TCM scanning and non-TCM
scanning at this point is reasonable. The significant current drop at 25.5 cm is due to the
low tissue density. The anatomy organ at this point is intestine which is low density region
due to hollow organ therefore, under TCM mode the low attenuation caused low current.
The second significance is that the end point of scanning (25.8 cm effective diameter) had
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significantly lower dose due to the missing of scattering dose because there was no any
additional material but only air therefore much less scattering in air than phantom.
Furthermore, the large error bars in TCM scanning showed the large current variations and
the size impact.
The dose reduction impact of TCM on skin dose measurement in our study is significant.
However, large current difference can cause the significant result in TCM scanning.
Another issue is the pitch factor. In our study 0.828 had been chosen for both TCM and
non-TCM which means that overlap happened during CT scan and the overlap dose
increases with the increases of current (Nagel, 2000). The explanation is that in dose profile
with a small pitch factor the overlap is larger; therefore more overlap doses will contribute
to the total dose. In our phantom experiment the non-TCM current was much higher than
the current of TCM scanning and therefore the overlap doses were higher than TCM
scanning overlap doses. Two edge measurement points had significantly low skin doses
compared with other measurement points. The reason is that the first and the last
measurement points missed some overlap skin doses. The starting dose profile and the last
dose profile missed the overlap dose from other dose profiles. The scattering doses and
penumbra effect doses from chest and pelvis respectively were missed. The scattering from
lungs are not significant due to the less scattering from air in the lungs. The missed skin
dose from pelvis will be significant due to the high scattering from pelvis.
4.3.2 Size impact on phantom skin dose and CTDIvol
The patient size (volume) was determined by effective diameter (x-y section) and scanning
length (z direction) therefore the impact of size on skin dose was examined on two parts:
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effective diameter impact and scanning length impact. The relationship between effective

dose messurement (mGy)

diameter and skin dose was examined on adult phantom and the results were investigated.
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Figure 45 The relationship between effective diameter and skin dose on phantom under 35 cm
scanning length. The size values are in an order of the smallest to the largest which represented the
measurement points on phantom in an order of 4, 3, 5, 2, 1 (see Table 4). The scanning start point
is point 1 of chest and the scanning end point is point 5 of pelvis on phantom. The error bars
represented the standard deviations.

In the figure it is shown that the skin doses were slightly increasing following the increase
of effective diameters in both TCM and non-TCM scanning except two edge points, the
third point (25.8 cm, the end point of the scanning) and the fifth point (27.5 cm, the start
point of the scanning) due to the missing scattering dose, which is similar with the result
shown in Figure 36. Furthermore, the difference between non-TCM skin dose measurement
and TCM skin dose measurement was larger on small size patient, which is the same with
the results shown in Table 8. Again, the error variations of TCM were higher than nonTCM can be seen significantly here which showed the size impact on skin dose. The skin
dose variations (error bars) were not significant in non-TCM scanning (0.67 mGy) while
significant in TCM scanning (2.31 mgy) due to the size impact which was reflected on the
current change in TCM mode.
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After we extended the scanning length towards the chest region the significantly affected
measurement point will be the start point of scanning on phantom (point 1 on phantom, the
fifth point in Figure 45, see Table 4 & Figure 9 due to that more scatterings were counted
theoretically. Furthermore, the dose estimation of 35 cm length scanning should be higher
than 25 cm length scanning due to the need of more photons to penetrate through larger
scanning area.
The results in Figure 46 next showed exactly the results supposed to be in the phantom
experiment. The scanning start point’s skin dose (point 1 on phantom, the fifth point in
Figure 46) in 35 cm scanning increased following the increasing trend rather than dropped

CTDIvol (mGy)

in 25 cm scanning (Figure 46).
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Figure 46 The CTDIvols of 25 cm (variation 0.09 mGy) and 35 cm (variation 0.08 mGy) different
scanning lengths of Philips CT scanner on phantom. The size values are in an order of the smallest
to the largest which represented the measurement points on phantom in an order of 4, 3, 5, 2, 1 (see
Table 4). The scanning start point is point 1 of chest and the scanning end point is point 5 of pelvis
on phantom. Under same TCM scanning the variations were not significant different due to same
scanning protocols.
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In our controlled study the patient size factor played an important role. For the patient with
larger thickness or size, more photons are needed to penetrate through the tissues which
reflected on skin dose.
Limitations of current experiment verification
However, in this study we did not measure the skin dose outside of the scanning field on
the back of the phantom, which means that our result can be under-estimated due to the
lack of consideration of scattering and penumbra effect and the presence of in-homogeneity
of scanning region in reality. Furthermore, in our study the pre-calibration factor done by
CMRP has been used (but not published) for the skin dose measurement. However, the
calibration factor can be affected by the reality of experiment, such as the temperature, the
sensitivity reproducibility under different scanner and longer scanning time, the different
energy and the related linearity. The temperature in our study was not exactly same
temperature in calibration as treatment. Furthermore, the temperature dependence of
MOSkin dosimeters relies on the CT machine output, such as thermostable current and
demonstrates the effectiveness of the in-built temperature compensation of the MOSkin
dosimeter though the MOSkin dosimeter is potentially temperature independent. The
sensitivity of MOSkin dosimeter decays with additional dose with respect to the change in
gate threshold voltage. Though there is no significant sensitivity difference between shorter
waiting time and longer waiting time after one single scan for MOSkin dosimeter, the
sensitivity still can be affected during the threshold voltage change. In our experiment the
waiting time interval was 30 seconds to 1 minute therefore the skin dose reading results can
have a small difference compared with that of longer waiting interval. Therefore, the skin
dose measurements can be affected. The only similarity of the calibration test and our
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experiment study is the phantom used, which is the anthropomorphic phantom because the
geometric factor of a phantom can show different variety of the dosimeter’s sensitivity
dependency of temperature, energy and angle. Furthermore, due to the same scanning TCM
mode the CTDIvol variation (the error bars, which were reflected the cross section size
impact) difference between 25 cm and 35 cm length scanning were not significant 0.08
mGy for 25 cm scanning length, 0.09mGy for 35 cm scanning length).
The phantom results have similarities with the results based on clinical patients’ data.
However, due to the number limit of dosimeter reading channels more studies based on
both clinic and laboratory are still needed accompanied with the update of dosimeter
technology, such as more numbers of dosimeter reading channels, higher reproducibility
and high sensitivity. In our study the scanning length of the phantom was not long enough.
Some absorbed and scattered photons were missing due to the limited cut-offs of the
phantom. For further research the whole body phantom scanning will be suggested.
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Chapter 5 Conclusion

In this thesis study, we have successfully evaluated the CT dose level trend at St Vincent’s
Hospital in the past ten years (2007-2016). The impacts from patient sizes and tube current
modulations (TCM) were also investigated. The significant results and findings from this
study are included the following aspects:
(1) The CT dose levels at St Vincent’s Hospital from the retrospective CT patient
examinations carried out in 2007-2016 were generally within the Australian national
diagnostic reference levels. Large dose level variations were highly associated with
either the CT facility or scanning protocol upgrades. These indicated that it’s
necessary to re-evaluate the dose levels for every CT technology and scanning
protocol upgrades.
(2) Using the CTDIvols for the patient CT dose estimations exhibits large variations
with patient sizes from the abdomen MDCT examinations. SSDE provides an
improved CT dose measure than CTDIvol for patient dose estimations. Our
proposed SSDE calculation method using average CTDIvol showed high agreement
with the alternative AAPM approach and provided higher computing efficiency
with the benefit of time saving (10 seconds for one slice, the center slice
measurement compared to 600 seconds for 60 slices measurements).
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(3) The preliminary phantom experiments showed that TCM has a significant impact on
the skin doses. The skin doses from the abdomen TCM scans were reduced by 2447% as compared to the non-TCM scans in this study.
However, the current SSDE calculations are still based on the standardized homogenous
phantoms for the generation of conversion factors. It does not take into account variations
in

composition

and

density

among

patients.

These

limit

the

accuracy

of

SSDE. Further improvements on SSDE can be pursued with attenuation-based patient size
approach.
The experimental evaluation of the CT dose in this thesis was very limited with five points’
skin dose measurements. Future study will focus on the organ dose estimations from inphantom measurements and in-vivo dosimetry during patient CT examinations.
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APPENDIX A Recommended diagnostic reference levels table for CT
examinations in IAEA, 1999, No. 28 based on pilot study.
Scan region

(mGy)

DLP (mGy.cm)

Face and sinuses

35

360

Petrous bone

60 (head)

1050 (head)

Orbits

60 (head)

1050 (head)

Sella and Hypophysis

60 (head)

1050 (head)

Salivary Glands

60 (head)

1050 (head)

Pharynx

60 (head)

1050 (head)

Larynx

60 (head)

1050 (head)

Vertebral and Paravertebral

70

460

35 (abdomen)

800 (abdomen)

Spinal Cord

30/35 (chest/abdomen)

650/800 (chest/abdomen)

Chest general

30

650

Chest, Mediastinal vessels

30

650

Chest, HRCT(high resolution

35

280

Abdomen, general

35

780

Liver and spleen

35

900

Kidneys

35 (abdomen)

800 (abdomen)

Pancreas

35 (abdomen)

800 (abdomen)

Adrenal glands

35 (abdomen)

800 (abdomen)

Pelvis, general

35

570

Osseous pelvis

25

520

Osseous shoulder

No specific value

No specific value

structures
Lumbar Spine, Discal
Herniation

CT)
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